Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 693
interventional 470
Observational 198
Registry 25

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 168
Drug|placebo 82
Procedure 36
Device 26
Other 26
Biological 25
Dietary Supplement 17
Diagnostic Test 15
Drug|Other 9
Drug|Procedure 8
Behavioral 7
Dietary Supplement|placebo 7
Biological|Drug 5
Biological|placebo 5
Other|Procedure 5
Dietary Supplement|Other 4
Behavioral|Other 3
Device|Other 3
Device|Drug 2
Drug|placebo|Procedure 2
Behavioral|Dietary Supplement|placebo 1
Behavioral|Drug|placebo 1
Behavioral|Procedure 1
Biological|Drug|placebo 1
Biological|Other 1
Combination Product 1
Combination Product|Drug 1
Device|Drug|Procedure 1
Device|placebo 1
Device|Procedure 1
Diagnostic Test|Drug|Procedure 1
Dietary Supplement|Drug|Other 1
Dietary Supplement|Drug|placebo 1
Drug|Other|placebo 1
Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 97
China 51
NA 39
India 35
Spain 26
France 22
Korea, Republic of 18
United Kingdom 14
Italy 13
Mexico 10
Denmark 8
Egypt 8
Japan 8
Austria 7
Canada 6
Germany 6
Iran, Islamic Republic of 6
Taiwan 6
United States|Canada 6
Brazil 4
United States|Puerto Rico 4
Bulgaria 3
Indonesia 3
Poland 3
Australia 2
Belgium|Netherlands 2
France|Germany|Italy|Netherlands|Spain|United Kingdom 2
Romania 2
Singapore 2
Switzerland 2
United States|Canada|United Kingdom 2
United States|Israel 2
United States|Japan 2
Argentina|Australia|Belgium|Canada|Croatia|Czech Republic|France|Germany|Hungary|Italy|Romania|Spain 1
Argentina|Australia|Belgium|Canada|Croatia|Czech Republic|France|Germany|Italy|Spain|Taiwan 1
Austria|Czech Republic|Denmark|Finland|France|Germany|Hong Kong|Italy|Poland|Spain|Taiwan|United Kingdom 1
Belgium|France 1
Belgium|France|Australia|United States|Germany|Hong Kong|Italy|Poland|Spain|United Kingdom 1
China|Korea, Republic of 1
Cuba 1
Ecuador 1
France|Belgium 1
France|Germany|Netherlands 1
France|Italy|Portugal|Spain|Switzerland|United Kingdom 1
France|United States|Austria|Canada|Germany|Netherlands|Spain|United Kingdom 1
Guadeloupe 1
Hong Kong|Korea, Republic of|Singapore|Taiwan|Vietnam 1
Israel 1
Malaysia 1
Mongolia 1
Portugal 1
Slovakia 1
Sweden 1
Thailand 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Chile|Denmark|Estonia|Finland|France|Germany|Hong Kong|Hungary|Israel|Italy|Korea, Republic of|Lithuania|Mexico|Netherlands|New Zealand|Poland|Portugal|Serbia|Spain|Sweden|Switzerland|Turkey|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|France|Georgia|Germany|Greece|Hong Kong|Hungary|India|Israel|Italy|Latvia|Mexico|New Zealand|Norway|Peru|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Singapore|Slovenia|Spain|Switzerland|Taiwan|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|Chile|Croatia|Denmark|France|Hungary|Israel|Italy|Netherlands|Poland|Portugal|Romania|Russian Federation|Spain|Sweden|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|Estonia|Germany|Hungary|Italy|Lithuania|Spain 1
United States|Argentina|Australia|Belgium|Canada|Croatia|Czech Republic|France|Germany|Hungary|Italy|Romania|Spain 1
United States|Argentina|Belgium|Canada|Czechia|Egypt|Estonia|France|Germany|Hong Kong|India|Israel|Italy|Latvia|Portugal|Russian Federation|Singapore|Spain|Switzerland|Turkey|United Kingdom 1
United States|Australia 1
United States|Australia|Austria|Belgium|Canada|France|Germany|Italy|Netherlands|Poland|Spain|Sweden|United Kingdom 1
United States|Australia|Belgium|Brazil|France|Germany|Hong Kong|Italy|Poland|Puerto Rico|Spain|United Kingdom 1
United States|Australia|Belgium|France|Germany|Poland|Puerto Rico|Spain|United Kingdom 1
United States|Australia|Canada|China|France|Germany|India|Israel|Korea, Republic of|Latvia|Malaysia|New Zealand|Poland|Russian Federation|Singapore|Spain|Taiwan|Thailand|Turkey|United Kingdom|Vietnam 1
United States|Australia|Canada|Czechia|Germany|Israel|Korea, Republic of|Malaysia|New Zealand|Puerto Rico|Romania|Russian Federation|Singapore|Taiwan 1
United States|Australia|Canada|France|Germany|Hungary|New Zealand|Poland|Puerto Rico|Spain|Ukraine|United Kingdom 1
United States|Australia|Canada|France|Germany|Japan|Korea, Republic of|Poland|Spain|United Kingdom 1
United States|Australia|France|New Zealand|Spain 1
United States|Australia|New Zealand 1
United States|Austria|Canada|France|Germany|Spain|United Kingdom 1
United States|Belgium|Bulgaria|Canada|Estonia|Germany|Japan|Russian Federation|Spain|Taiwan|United Kingdom 1
United States|Belgium|Denmark 1
United States|Belgium|Denmark|France|Germany|Italy|Spain|United Kingdom 1
United States|Belgium|Germany|South Africa 1
United States|Bulgaria|Canada|Czechia|France|Greece|Hungary|Ireland|Israel|Italy|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Spain|Taiwan|United Kingdom|Vietnam 1
United States|Canada|France|Italy|Switzerland|United Kingdom 1
United States|France|Spain|Switzerland 1
United States|Germany|Spain 1
United States|Russian Federation 1
United States|Spain|United Kingdom 1
Vietnam 1

Sites per Study

Site_count Study_Count
1 325
2 26
3 13
4 8
5 7
6 10
7 3
8 4
9 5
10 3
11 4
12 4
13 2
15 3
16 1
17 2
18 1
19 2
20 3
21 4
22 1
23 1
24 2
25 1
28 3
31 1
32 1
33 2
34 2
35 1
38 1
41 2
44 1
45 1
46 2
49 1
50 1
58 1
59 1
65 1
74 1
76 1
91 2
92 1
97 1
113 1
121 3
180 1
227 1
598 1

Phase

Phase Study_Count
N/A 182
Phase 2 82
Phase 3 74
Phase 4 58
Phase 1 32
Phase 1/Phase 2 24
Phase 2/Phase 3 15
Early Phase 1 3

Number of Arms

Number_of_Arms Count_of_Studies
1 132
2 219
3 55
4 17
5 1
6 2
7 5
8 1
9 2
11 1
12 1
NA 34

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 3.00000 4.0000 2.00000 6.00000 5.00000 10.0000 6.0000 5.0000
1st Qu. 30.50000 42.0000 10.00000 18.75000 22.00000 48.0000 75.5000 54.0000
Median 58.00000 83.0000 20.00000 30.00000 58.50000 65.0000 125.0000 100.0000
Mean 70.33333 184.0497 38.78125 46.66667 99.52439 168.2308 273.4444 185.9298
3rd Qu. 104.00000 185.0000 31.00000 54.00000 149.50000 124.0000 276.2500 238.0000
Max. 150.00000 3975.0000 275.00000 266.00000 560.00000 1010.0000 2333.0000 1200.0000

Trial Group Type

group_type Group_Count
Experimental 496
Active Comparator 186
Placebo Comparator 128
No Intervention 48
Other 41
NA 34
Sham Comparator 5

Intervention Model

intervention_model Study_Count
Parallel Assignment 286
Single Group Assignment 156
Crossover Assignment 12
NA 7
Sequential Assignment 5
Factorial Assignment 4

Primary Purpose

primary_purpose Study_Count
Treatment 299
Diagnostic 62
Prevention 43
Supportive Care 18
Other 14
Basic Science 13
NA 11
Screening 7
Health Services Research 2
Device Feasibility 1

Observational Studies

Studies by Country

Country Study_Count
United States 34
China 21
NA 14
France 13
Denmark 10
Germany 10
India 9
Mexico 7
United Kingdom 7
Hong Kong 5
Korea, Republic of 5
Taiwan 5
Egypt 4
Israel 4
Spain 4
Zambia 4
Brazil 3
Italy 3
Poland 3
Switzerland 3
Australia 2
Austria 2
Belgium 2
Russian Federation 2
United States|Canada 2
Argentina 1
Belgium|China|Denmark|France|Germany|Greece|Hong Kong|Italy|Romania 1
Brazil|China|Indonesia|Italy|Japan|Korea, Republic of|Turkey 1
Canada 1
China|Indonesia|Japan|Thailand|Turkey 1
China|Thailand|Turkey 1
Croatia|Denmark|France|Netherlands|Spain|United Kingdom 1
Czechia 1
Finland 1
Germany|Italy 1
Greece 1
Japan 1
Korea, Republic of|Russian Federation 1
Korea, Republic of|Taiwan 1
Latvia 1
Netherlands|United Kingdom 1
Slovenia 1
Spain|Austria|Belgium|Denmark|France|Germany|Hungary|Italy|Netherlands|Portugal|Slovakia|Switzerland|Turkey|United Kingdom 1
Switzerland|United Kingdom 1
Turkey 1

Sites per Study

Site_count Study_Count
1 156
2 15
3 1
4 3
5 1
7 1
9 3
10 2
11 1
12 1
13 1
14 3
15 2
16 1
17 1
19 1
25 1
26 1
30 1
45 1
57 1

Enrollment Metrics

Measure Observational
Min 7.00
1st Qu 55.50
Median 146.00
Mean 510776.02
3rd Qu 444.75
Max 99999999.00

Observation Model

observational_model Study_Count
Cohort 126
Case-Only 26
Case-Control 21
Other 9
Case Control 5
NA 4
Case-Crossover 3
Family-Based 2
Defined Population, Natural History 1
Ecologic or Community 1

Time Perspective

time_perspective Study_Count
Prospective 154
Cross-Sectional 20
Retrospective 13
Other 7
NA 3
Cross-Sectional, Retrospective 1

Registries

Studies by Country

Country Study_Count
China 5
Korea, Republic of 4
Switzerland 2
Taiwan 2
Austria 1
Belgium|Finland|France|Germany|Greece|Italy|Netherlands|Portugal|Spain|Sweden|Switzerland|United Kingdom 1
Denmark 1
France 1
Germany|Switzerland 1
India 1
Italy 1
Japan 1
Spain 1
United Kingdom 1
United States 1
United States|Australia|Canada|France|Germany|Italy|New Zealand|Puerto Rico|Spain|United Kingdom 1

Sites per Study

Site_count Study_Count
1 16
2 1
6 1
7 1
8 1
15 1
23 1
30 1
37 1
138 1

Enrollment Metrics

Measure Registries
Min 8.00
1st Qu 200.00
Median 500.00
Mean 1302.52
3rd Qu 1000.00
Max 10000.00

Registry Model

observational_model Study_Count
Cohort 20
Case-Only 2
Other 2
Case-Control 1

Time Perspective

time_perspective Study_Count
Prospective 21
Cross-Sectional 3
Other 1

Follow-up

target_duration Study_Count
10 Years 5
2 Years 4
5 Years 4
3 Years 3
20 Years 2
1 Day 1
1 Year 1
12 Months 1
192 Weeks 1
3 Months 1
6 Months 1
6 Weeks 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03176797 Quantitative Diagnosis of Liver Fibrosis on Multiparametric MRI https://ClinicalTrials.gov/show/NCT03176797 Enrolling by invitation Zhujiang Hospital 2021-07-31
NCT04060147 Safety and Tolerability of Cilofexor in Participants With Primary Sclerosing Cholangitis (PSC) and Compensated Cirrhosis https://ClinicalTrials.gov/show/NCT04060147 Recruiting Gilead Sciences 2021-06-30
NCT03957070 The Sonic Incytes Liver Incyte System, Assessment of Liver Fibrosis and Steatosis https://ClinicalTrials.gov/show/NCT03957070 Recruiting Sonic Incytes 2020-10-31
NCT03407001 Contrast Enhanced Ultrasound With Lumason in Detecting Liver Cancer in Participants With Cirrhosis https://ClinicalTrials.gov/show/NCT03407001 Recruiting M.D. Anderson Cancer Center 2021-09-30
NCT03388151 Propofol Versus Midazolam for Lower Gastrointestinal Endoscopy https://ClinicalTrials.gov/show/NCT03388151 Recruiting Tanta University 2022-11-11
NCT03373396 Impact of Chlordecone on Active Chronic Hepatitis https://ClinicalTrials.gov/show/NCT03373396 Completed Centre Hospitalier Universitaire de Pointe-a-Pitre 2015-12-21
NCT03368066 Is Adrenal Insufficiency Under-diagnosed in Hospitalized Cirrhosis Patients? https://ClinicalTrials.gov/show/NCT03368066 Completed University of Virginia 2019-03-12
NCT03826433 Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells(19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosis https://ClinicalTrials.gov/show/NCT03826433 Recruiting Sclnow Biotechnology Co., Ltd. 2020-06-30
NCT03871894 Indirect Calorimeter Based Study in Patients With Liver Cirrhosis https://ClinicalTrials.gov/show/NCT03871894 Recruiting Institute of Liver and Biliary Sciences, India 2021-01-31
NCT03363412 Tips Underdilatation in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT03363412 Completed University of Modena and Reggio Emilia 2012-12-31
NCT03354299 Effect of Coconut Milk Supplementation to Improve Nutritional Status in Cirrhosis Patient https://ClinicalTrials.gov/show/NCT03354299 Completed Dr Cipto Mangunkusumo General Hospital 2014-07-31
NCT03342560 Beyond Confounders: Addressing Source of Measurement Variability and Error in Shear Wave Elastography https://ClinicalTrials.gov/show/NCT03342560 Completed Massachusetts General Hospital 2018-08-14
NCT03339232 BCAA Supplemental Study https://ClinicalTrials.gov/show/NCT03339232 Completed Loyola University 2019-06-17
NCT03337945 In Vivo Determination of Cytochrome P450 Activities in Patients With Liver Cirrhosis https://ClinicalTrials.gov/show/NCT03337945 Recruiting University Hospital, Basel, Switzerland 2019-12-31
NCT03318380 Contrast-Enhanced Ultrasound Imaging in Diagnosing Liver Cancer in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT03318380 Recruiting Thomas Jefferson University 2020-07-31
NCT03311152 Circulating Cell-free DNA-based Epigenetic Biomarker mSEPT9 for Hepatocellular Carcinoma Detection in Cirrhosis https://ClinicalTrials.gov/show/NCT03311152 Recruiting Central Hospital, Nancy, France 2021-02-12
NCT03285217 HMB for Denutrition in Patients With Cirrhosis (HEPATIC) https://ClinicalTrials.gov/show/NCT03285217 Active, not recruiting Instituto Aragones de Ciencias de la Salud 2018-03-31
NCT03278925 Defined Green Tea Catechin Extract in Preventing Liver Cancer in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT03278925 Recruiting National Cancer Institute (NCI) 2021-01-15
NCT03254758 A Study of ADR-001 in Patients With Liver Cirrhosis https://ClinicalTrials.gov/show/NCT03254758 Recruiting Rohto Pharmaceutical Co., Ltd. 2019-12-31
NCT03235349 Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With Compensated Cirrhosis and With or Without Human Immunodeficiency Virus Co-Infection https://ClinicalTrials.gov/show/NCT03235349 Completed AbbVie 2018-11-15
NCT03219372 Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence https://ClinicalTrials.gov/show/NCT03219372 Recruiting Cedars-Sinai Medical Center 2021-06-01
NCT03208868 Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis https://ClinicalTrials.gov/show/NCT03208868 Recruiting The Cleveland Clinic 2020-12-31
NCT03205345 Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis https://ClinicalTrials.gov/show/NCT03205345 Active, not recruiting Conatus Pharmaceuticals Inc. 2019-08-31
NCT03202498 Safety and Tolerability of Yaq-001 in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT03202498 Recruiting Yaqrit Ltd 2020-08-30
NCT03191851 Evaluation of ‘Melody’ Paracentesis Device for Ascites Therapy https://ClinicalTrials.gov/show/NCT03191851 Completed University of Nottingham 2019-01-10
NCT03176966 Ropinirole for the Treatment of Muscle Cramps in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT03176966 Enrolling by invitation Vanderbilt University Medical Center 2022-06-30
NCT03172273 Early Use of TIPS With Polytetrafluoroethylene(PTFE) Covered Stents in Cirrhotic Patients With Refractory Ascites https://ClinicalTrials.gov/show/NCT03172273 Recruiting Fourth Military Medical University 2022-09-18
NCT03171805 The Use of Propranolol for the Prevention of Worsening of Esophageal Varices in Patients With Isolated Gastric Varices https://ClinicalTrials.gov/show/NCT03171805 Recruiting West China Hospital 2020-05-15
NCT03171727 Low Molecular Weight Heparin for the Prevention of Early TIPS Dysfunction https://ClinicalTrials.gov/show/NCT03171727 Recruiting West China Hospital 2019-05-15
NCT03139058 Prevalence of Liver Fibrosis and Cirrhosis in Patients With Squamous Cell Carcinoma of the Head and Neck https://ClinicalTrials.gov/show/NCT03139058 Recruiting Centre Hospitalier Universitaire, Amiens 2019-06-20
NCT03152188 Oral Fecal Transplant in Cirrhosis https://ClinicalTrials.gov/show/NCT03152188 Completed Virginia Commonwealth University 2018-11-12
NCT03150459 Simvastatin Plus Rifaximin in Decompensated Cirrhosis https://ClinicalTrials.gov/show/NCT03150459 Completed Institut d’Investigacions Biomèdiques August Pi i Sunyer 2018-03-12
NCT03144713 Efficacy and Safety of Terlipressin With Albumin Versus Midodrine With Albumin Versus Albumin Alone in Prevention of Paracentesis Induced Circulatory Dysfunction in Cirrhosis https://ClinicalTrials.gov/show/NCT03144713 Completed Institute of Liver and Biliary Sciences, India 2018-04-30
NCT03123666 Recombinant Human Granulocyte Monocyte - Colony Stimulating Factor (GM CSF) for Prevention of Pneumonia in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT03123666 Active, not recruiting Institute of Liver and Biliary Sciences, India 2020-10-19
NCT03120637 Evaluating in Cirrhotics With Refractory Vasoplegia the Effect of Methylene Blue https://ClinicalTrials.gov/show/NCT03120637 Completed Institute of Liver and Biliary Sciences, India 2018-01-10
NCT03109236 Autologous Endothelial Progenitor Cell Therapy for Reversal of Liver Cirrhosis https://ClinicalTrials.gov/show/NCT03109236 Recruiting National University Hospital, Singapore 2020-03-31
NCT03107091 Continuous Infusion Terlipressin for Patients With Cirrhosis and Refractory Ascites https://ClinicalTrials.gov/show/NCT03107091 Completed BioVie Inc. 2019-04-01
NCT03089944 A Study of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults With Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Compensated Cirrhosis https://ClinicalTrials.gov/show/NCT03089944 Completed AbbVie 2019-07-31
NCT03087344 Postprandial Liver and Spleen Stiffness Measurements in the Noninvasive Diagnosis of Cirrhosis https://ClinicalTrials.gov/show/NCT03087344 Completed VA Connecticut Healthcare System 2018-06-30
NCT03070353 Dextran, a Plasma Expander, Offers New Hope for Patients With Decompensated Liver Cirrhosis and Acute Kidney Injury https://ClinicalTrials.gov/show/NCT03070353 Completed Ramathibodi Hospital 2016-06-30
NCT03069339 Carvedilol, Endoscopic Variceal Ligation or Combination of Both for Prevention of First Variceal Bleed in Child’s B & C Cirrhosis https://ClinicalTrials.gov/show/NCT03069339 Active, not recruiting Institute of Liver and Biliary Sciences, India 2020-11-30
NCT03059446 Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT03059446 Enrolling by invitation Tobira Therapeutics, Inc. 2029-11-27
NCT03059030 Yttrium-90 Radioembolization for Cirrhosis-Associated Thrombocytopenia https://ClinicalTrials.gov/show/NCT03059030 Recruiting Northwestern University 2020-04-01
NCT03047707 S-Shearwave Elastography for Assessment of Hepatic Fibrosis https://ClinicalTrials.gov/show/NCT03047707 Completed Seoul National University Hospital 2018-04-24
NCT03030820 Oral Gut Liver Axis in Cirrhosis https://ClinicalTrials.gov/show/NCT03030820 Completed Virginia Commonwealth University 2018-03-31
NCT03018990 Alcohol Challenge On Liver and Gut Measured by Liver Vein Catheterization. A Pathophysiological Intervention Trial https://ClinicalTrials.gov/show/NCT03018990 Active, not recruiting Odense University Hospital 2018-11-12
NCT03005444 Anticoagulation for Advanced Cirrhotic Patients After TIPS https://ClinicalTrials.gov/show/NCT03005444 Recruiting Fourth Military Medical University 2020-12-31
NCT02996682 Efficacy and Safety of Sofosbuvir/Velpatasvir ± Ribavirin for 12 Weeks in Adults With Chronic HCV Infection and Decompensated Cirrhosis https://ClinicalTrials.gov/show/NCT02996682 Completed Gilead Sciences 2018-02-13
NCT02968810 Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis https://ClinicalTrials.gov/show/NCT02968810 Recruiting National Cancer Institute (NCI) 2021-04-14
NCT02967198 Pre-procedure Planning for Liver Biopsy or Radiofrequency Ablation Using CT or MR/US Fusing Imaging https://ClinicalTrials.gov/show/NCT02967198 Completed Seoul National University Hospital 2016-09-30
NCT02965131 The Effects of the Anhepatic Phase Extended by Temporary Portocaval Shunt on Anesthetic Sensitivity and Cognitive Function https://ClinicalTrials.gov/show/NCT02965131 Completed Daegu Catholic University Medical Center 2016-01-31
NCT02960204 Emricasan, an Oral Caspase Inhibitor, in Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension https://ClinicalTrials.gov/show/NCT02960204 Completed Conatus Pharmaceuticals Inc. 2018-10-02
NCT02957253 Effects on Liver Cirrhotic Patients’ by a Nurse-led Clinic https://ClinicalTrials.gov/show/NCT02957253 Recruiting Uppsala University 2022-12-31
NCT02949505 Impact of Exercise Therapy on Functional Capacity in Patients Listed for Liver Transplantation https://ClinicalTrials.gov/show/NCT02949505 Completed University of Birmingham 2017-10-01
NCT02944643 Mindfulness and Support Group to Improve Patient and Caregiver Burden in Cirrhosis https://ClinicalTrials.gov/show/NCT02944643 Completed Hunter Holmes Mcguire Veteran Affairs Medical Center 2017-01-31
NCT02936596 Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome https://ClinicalTrials.gov/show/NCT02936596 Recruiting West China Hospital 2020-06-01
NCT02923336 Evaluation of Gastrointestinal Transit Pre and Pos Treatment With Non Selective Betablocker in a Population of Cirrhotics https://ClinicalTrials.gov/show/NCT02923336 Recruiting Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 2019-01-31
NCT02907749 Spironolactone on Fibrosis Progrssion-Portal Hypertension(FP-PH)in Cirrhosis https://ClinicalTrials.gov/show/NCT02907749 Active, not recruiting Shanghai Tongji Hospital, Tongji University School of Medicine 2020-06-01
NCT02862249 Trial of Faecal Microbiota Transplantation in Cirrhosis https://ClinicalTrials.gov/show/NCT02862249 Recruiting King’s College London 2020-05-31
NCT02859610 Microparticles in Cirrhosis and Portal Hypertension https://ClinicalTrials.gov/show/NCT02859610 Completed Centre Hospitalier Universitaire de Besancon 2015-01-31
NCT02854241 Comparison of Biannual Ultrasonography and Annual Unenhanced Magnetic Resonance Imaging for HCC Surveillance https://ClinicalTrials.gov/show/NCT02854241 Active, not recruiting Seoul National University Hospital 2020-09-30
NCT02849132 Effect of Entecavir Treatment on Regression and Disease Outcome in HBV-induced Liver Fibrosis and Cirrhosis Patients https://ClinicalTrials.gov/show/NCT02849132 Active, not recruiting Beijing Friendship Hospital 2020-12-31
NCT02837939 Transfer Factor Efficacy in the Management of Cirrhosis-associated Immune Dysfunction https://ClinicalTrials.gov/show/NCT02837939 Recruiting Pavol Jozef Safarik University 2020-07-31
NCT02811887 SMS-based Lifestyle Intervention for Patients With Liver Cirrhosis With Previous Hepathic Encephalopathy https://ClinicalTrials.gov/show/NCT02811887 Recruiting Frederiksberg University Hospital 2022-10-31
NCT02802228 Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patients https://ClinicalTrials.gov/show/NCT02802228 Completed Cumberland Pharmaceuticals 2018-07-17
NCT02786017 Injectable Collagen Scaffoldâ„¢ Combined With HUC-MSCs Transplantation for Patients With Decompensated Cirrhosis https://ClinicalTrials.gov/show/NCT02786017 Recruiting Chinese Academy of Sciences 2020-12-31
NCT02778425 The Treatment of Hepatocirrhosis and Portal Hypertension https://ClinicalTrials.gov/show/NCT02778425 Recruiting Qilu Hospital of Shandong University 2019-02-28
NCT02705534 Sofosbuvir, Ledipasvir, Ribavirin for Hepatitis C Cirrhotics, Genotype 1 https://ClinicalTrials.gov/show/NCT02705534 Completed Tehran University of Medical Sciences 2017-09-30
NCT02702739 Sofosbuvir/Simeprevir Plus a Flat Dose of Ribavirin in Genotype 1 Elderly HCV Cirrhotic Patients https://ClinicalTrials.gov/show/NCT02702739 Completed Azienda Ospedaliera San Camillo Forlanini 2015-12-31
NCT02695628 [18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver Cancer https://ClinicalTrials.gov/show/NCT02695628 Completed Stanford University 2018-04-30
NCT02669875 Serelaxin To Lower Portal Pressure https://ClinicalTrials.gov/show/NCT02669875 Completed University of Edinburgh 2018-08-31
NCT02642874 Methocarbamol in Treatment of Muscle Cramps in Cirrhotic Patients https://ClinicalTrials.gov/show/NCT02642874 Recruiting Tanta University 2020-12-31
NCT02642003 To Assess the Efficacy of Granulocyte Colony Stimulating Factor Versus Standard Medical Therapy in Patients of Decompensated Cirrhosis https://ClinicalTrials.gov/show/NCT02642003 Completed Sir Ganga Ram Hospital 2016-01-31
NCT02636647 Fecal Transplant in Recurrent Hepatic Encephalopathy https://ClinicalTrials.gov/show/NCT02636647 Completed Hunter Holmes Mcguire Veteran Affairs Medical Center 2016-08-31
NCT02608658 Evaluation of Serum-Derived Bovine Immunoglobulin Protein Isolate in Subjects With Decompensated Cirrhosis With Ascites https://ClinicalTrials.gov/show/NCT02608658 Completed St. Louis University 2017-04-27
NCT02603666 Elastography of the Liver in Cystic Fibrosis Patients. Diagnostic and Prognostic Aspects https://ClinicalTrials.gov/show/NCT02603666 Completed Karolinska University Hospital 2014-06-30
NCT02597166 Effects of Harvoni in Patients With Decompensated Cirrhosis Due to Hepatitis C Genotype 1 Infection https://ClinicalTrials.gov/show/NCT02597166 Completed University Health Network, Toronto 2018-06-30
NCT02596880 Sofosbuvir, Daclatasvir, Ribavirin for Hepatitis C Virus (HCV) Cirrhotics https://ClinicalTrials.gov/show/NCT02596880 Completed Tehran University of Medical Sciences 2016-04-30
NCT04365868 Study Evaluating the Efficacy and Safety of Belapectin (GR-MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis https://ClinicalTrials.gov/show/NCT04365868 Recruiting Galectin Therapeutics Inc. 2023-06-30
NCT02557360 Effectiveness of S-adenosyl-L-methionine in Patients With Primary Biliary Cirrhosis https://ClinicalTrials.gov/show/NCT02557360 Completed Pomeranian Medical University Szczecin 2017-02-28
NCT02538874 A Study of BMS-986171 in Healthy People to Assess Safety, to Measure Blood Levels of Drug, and to Find Out What the Drug Does to the Body https://ClinicalTrials.gov/show/NCT02538874 Completed Bristol-Myers Squibb 2016-11-04
NCT02528760 To Determine the Role of Prokinetics in Feed Intolerance in Critically Ill Cirrhosis https://ClinicalTrials.gov/show/NCT02528760 Completed Institute of Liver and Biliary Sciences, India 2017-08-31
NCT02517528 ABT-450/Ritonavir/ ABT-267 (ABT-450/r/ABT-267) and ABT-333 Co-Administered With Ribavirin (RBV) in Treatment Naïve and Treatment Experienced Asian Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Compensated Cirrhosis https://ClinicalTrials.gov/show/NCT02517528 Completed AbbVie 2016-09-29
NCT02508688 Thoracoscopic Mesh Repair of Diaphragmatic Defects for Hepatic Hydrothorax https://ClinicalTrials.gov/show/NCT02508688 Completed National Taiwan University Hospital 2014-12-31
NCT02508298 Surrogate Markers of Portal Pressure https://ClinicalTrials.gov/show/NCT02508298 Completed VA Connecticut Healthcare System 2018-07-31
NCT02485184 TIPS vs Endoscopic Therapy for Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis https://ClinicalTrials.gov/show/NCT02485184 Recruiting Fourth Military Medical University 2021-12-31
NCT02484573 Evaluation of Intestinal Permeability in Cirrhotic Patients Before and After Treatment With Non-selective Beta Blocker (Propranolol) https://ClinicalTrials.gov/show/NCT02484573 Recruiting Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 2020-01-31
NCT02475928 Zinc Supplementation in Cirrhotic Patients https://ClinicalTrials.gov/show/NCT02475928 Recruiting Fundación Clínica Médica Sur 2019-12-31
NCT02468063 To Assess the Efficacy of Early Introduction of a Combination of Low Dose Vasopressin Analogue in Addition to Noradrenaline as a Vasopressor in Patients of Cirrhosis With Septic Shock https://ClinicalTrials.gov/show/NCT02468063 Completed Institute of Liver and Biliary Sciences, India 2017-05-31
NCT02462967 Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis https://ClinicalTrials.gov/show/NCT02462967 Completed Galectin Therapeutics Inc. 2017-10-31
NCT02462902 Comparison And Outcomes Of Fluid Resucitation With 0.9% Normal Saline And 5% Albumin In Cirrhosis Patients With Sepsis Induced Hypotension https://ClinicalTrials.gov/show/NCT02462902 Completed Institute of Liver and Biliary Sciences, India 2015-06-30
NCT02457403 Comparison of Blood Product Use and Bleeding Events During and After Endoscopic or Neurosurgical Procedures in Patients With Cirrhosis and Coagulopathy: Rotational Thromboelastometry Versus Conventional Therapy https://ClinicalTrials.gov/show/NCT02457403 Completed Ohio State University 2018-11-30
NCT02451033 Granulocyte Colony Stimulating Factor And Growth Hormone In Cirrhosis Of Liver: An Open Label Study https://ClinicalTrials.gov/show/NCT02451033 Completed Postgraduate Institute of Medical Education and Research 2016-06-30
NCT02439567 Transient Elastography to Assess Liver Fibrosis and Portal Hypertension in HCV Cirrhotic Patients Treated With New Antiviral Drugs (SPLEEN-C) https://ClinicalTrials.gov/show/NCT02439567 Completed Hospital Universitari Vall d’Hebron Research Institute 2016-07-31
NCT02423395 Study of Orphenadrine` in the Treatment of Muscle Cramps in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT02423395 Recruiting Tanta University 2028-12-31
NCT02421094 Clinical Trial to Evaluate Efficacy of GR-MD-02 for Treatment of Liver Fibrosis in Patients With NASH With Advanced Fibrosis https://ClinicalTrials.gov/show/NCT02421094 Completed Galectin Therapeutics Inc. 2016-09-27
NCT02414880 Sugammadex Versus Neostigmine in Patients With Liver Cirrhosis Undergoing Liver Resection https://ClinicalTrials.gov/show/NCT02414880 Completed Cairo University 2015-08-31
NCT02377141 Early Use of TIPSS in Patients With Cirrhosis and Variceal Bleeding https://ClinicalTrials.gov/show/NCT02377141 Completed University of Edinburgh 2019-01-31
NCT02376335 B-Cell Depleting Therapy (Rituximab) as a Treatment for Fatigue in Primary Biliary Cirrhosis https://ClinicalTrials.gov/show/NCT02376335 Completed Newcastle-upon-Tyne Hospitals NHS Trust 2016-03-31
NCT02367092 Exercise Intervention in Liver Transplant Patients https://ClinicalTrials.gov/show/NCT02367092 Completed University of California, San Francisco 2019-12-31
NCT02362178 Thromboelastographic Guide for Blood Products in Cirrhotics https://ClinicalTrials.gov/show/NCT02362178 Completed University of Modena and Reggio Emilia 2014-08-31
NCT02344719 Effect of Taurine on Portal Hemodynamics in Patients With Advanced Liver Cirrhosis https://ClinicalTrials.gov/show/NCT02344719 Completed Medical University of Vienna 2015-05-31
NCT02308111 Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis https://ClinicalTrials.gov/show/NCT02308111 Recruiting Intercept Pharmaceuticals 2024-12-31
NCT02297867 Clinical Trial Study About Human Adipose-Derived Stem Cells in the Liver Cirrhosis https://ClinicalTrials.gov/show/NCT02297867 Completed Gwo Xi Stem Cell Applied Technology Co., Ltd. 2017-12-18
NCT02273362 Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver https://ClinicalTrials.gov/show/NCT02273362 Active, not recruiting National Cancer Institute (NCI) 2020-02-11
NCT02265484 To Study the Efficacy of Bromocriptine in Patients With Hepatic/Cirrhosis Related Parkinsonism https://ClinicalTrials.gov/show/NCT02265484 Completed Institute of Liver and Biliary Sciences, India 2015-01-31
NCT02265237 A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir Co-administered With Ribavirin (RBV) in Adults With Genotype 4 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (AGATE-1) https://ClinicalTrials.gov/show/NCT02265237 Completed AbbVie 2016-07-28
NCT02256514 Open Label Trial of Immunotherapy for Advanced Liver Cancer https://ClinicalTrials.gov/show/NCT02256514 Enrolling by invitation Immunitor LLC 2019-09-30
NCT02254434 A Pharmacokinetic Study of Eltrombopag 50 Milligram (mg) in Healthy Volunteers Under Fasting Conditions https://ClinicalTrials.gov/show/NCT02254434 Completed GlaxoSmithKline 2014-09-08
NCT02249741 Prospective Study of Profile of Hepatic Osteodystrophy in Patients With Non-Choleastatic Liver Cirrhosis and Impact of Bisphosphonate Supplementation https://ClinicalTrials.gov/show/NCT02249741 Completed Sir Ganga Ram Hospital 2014-02-28
NCT02241616 Traditional Chinese Medicine Combined With Entecavir to Treat Refractory Liver Fibrosis in Liver Cirrhosis Due to HBV https://ClinicalTrials.gov/show/NCT02241616 Recruiting ShuGuang Hospital 2019-06-30
NCT02241590 Treatment of Liver Cirrhosis Due to Hepatitis B Virus With Fuzheng Huayu and Entecavir https://ClinicalTrials.gov/show/NCT02241590 Recruiting ShuGuang Hospital 2019-06-30
NCT02234440 Effect of Metformin on Disease Progression in Patients With Cryptogenic Cirrhosis (NASH-related Cirrhosis) With Diabetes or Impaired Glucose Tolerance or Insulin Resistance https://ClinicalTrials.gov/show/NCT02234440 Completed Institute of Liver and Biliary Sciences, India 2015-12-31
NCT02230683 A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension https://ClinicalTrials.gov/show/NCT02230683 Completed Conatus Pharmaceuticals Inc. 2015-05-31
NCT02230670 A Study of IDN-6556 in Subjects With Liver Cirrhosis https://ClinicalTrials.gov/show/NCT02230670 Completed Conatus Pharmaceuticals Inc. 2016-01-31
NCT02226939 Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Cirrhosis and Chronic Hepatitis C https://ClinicalTrials.gov/show/NCT02226939 Completed Boehringer Ingelheim 2002-11-30
NCT02224456 Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis https://ClinicalTrials.gov/show/NCT02224456 Active, not recruiting GlaxoSmithKline 2020-12-02
NCT02219503 A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis https://ClinicalTrials.gov/show/NCT02219503 Completed AbbVie 2015-06-30
NCT02219477 A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis https://ClinicalTrials.gov/show/NCT02219477 Completed AbbVie 2016-06-13
NCT02217475 Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver Fibrosis https://ClinicalTrials.gov/show/NCT02217475 Completed Tobira Therapeutics, Inc. 2016-06-30
NCT02201901 Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection and Child-Pugh Class B Cirrhosis https://ClinicalTrials.gov/show/NCT02201901 Completed Gilead Sciences 2015-08-31
NCT02195440 An Open Label, Single Arm, Dose Escalation Phase 1 Trial of PRI-724 in Patients With HCV-induced Cirrhosis https://ClinicalTrials.gov/show/NCT02195440 Completed Komagome Hospital 2017-03-31
NCT02173288 Role of Midodrine and Tolvaptan in Patients With Cirrhosis With Refractory or Recurrent Ascites https://ClinicalTrials.gov/show/NCT02173288 Completed Postgraduate Institute of Medical Education and Research 2016-03-31
NCT02156232 Embolization of Large Spontaneous Portosystemic Shunts for the Prevention of Post-TIPS Hepatic Encephalopathy https://ClinicalTrials.gov/show/NCT02156232 Recruiting Fourth Military Medical University 2020-12-31
NCT02151864 LDE225 in Patients With Advanced or Metastatic Hepatocellular Carcinoma and Child-Pugh A/B7 Cirrhosis https://ClinicalTrials.gov/show/NCT02151864 Completed University of California, San Diego 2016-12-31
NCT02143778 Assessing Portal Hypertension With Methacetin Breath Test https://ClinicalTrials.gov/show/NCT02143778 Completed Exalenz Bioscience LTD. 2018-12-31
NCT02138253 A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV https://ClinicalTrials.gov/show/NCT02138253 Completed Conatus Pharmaceuticals Inc. 2018-02-15
NCT02135536 Phase 2b Study of NGM282 Extended Treatment in Patients With Primary Biliary Cirrhosis https://ClinicalTrials.gov/show/NCT02135536 Completed NGM Biopharmaceuticals, Inc 2016-02-29
NCT02134626 Simvastatin Effect on Portal Hypertension https://ClinicalTrials.gov/show/NCT02134626 Completed Universidade Federal do Rio de Janeiro 2014-04-30
NCT02132962 Sarcopenia and Cirrhosis https://ClinicalTrials.gov/show/NCT02132962 Completed Rigshospitalet, Denmark 2015-10-31
NCT02120196 Comparative Study of Rifaximin Versus Norfloxacin in the Secondary Prophylaxis of Spontaneous Bacterial Peritonitis https://ClinicalTrials.gov/show/NCT02120196 Recruiting Tanta University 2023-12-31
NCT02119988 TIPS Combined With Variceal Embolization for the Prevention of Variceal Rebleeding in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT02119988 Recruiting Fourth Military Medical University 2020-12-31
NCT02114177 Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Chronic Hepatitis C Virus Infection Without Cirrhosis https://ClinicalTrials.gov/show/NCT02114177 Completed Janssen Infectious Diseases BVBA 2015-01-31
NCT02114151 Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Genotype 1 Chronic Hepatitis C Virus Infection and Cirrhosis https://ClinicalTrials.gov/show/NCT02114151 Completed Janssen Infectious Diseases BVBA 2015-01-31
NCT02085915 Evaluation of the Strip PeriScreen for the Fast Diagnosis of the Spontaneous Infection of the Liquid of Ascites During the Cirrhosis https://ClinicalTrials.gov/show/NCT02085915 Completed Centre Hospitalier Departemental Vendee 2015-08-31
NCT02068339 Efficacy and Safety of Oltipraz for Liver Fat Reduction in Patients With Non-Alcoholic Fatty Liver Disease Except for Liver Cirrhosis https://ClinicalTrials.gov/show/NCT02068339 Completed PharmaKing 2016-02-29
NCT01298271 A Randomized Trial of GVS Alone vs. Propranolol https://ClinicalTrials.gov/show/NCT01298271 Recruiting Taipei Veterans General Hospital, Taiwan 2025-12-31
NCT01289951 Pharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Patients With Advanced (Child-Pugh C) Hepatic Cirrhosis https://ClinicalTrials.gov/show/NCT01289951 Completed Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 2011-06-30
NCT01288794 Human Albumin for the Treatment of Ascites in Patients With Hepatic Cirrhosis https://ClinicalTrials.gov/show/NCT01288794 Completed University of Bologna 2014-11-30
NCT01283152 Efficacy Study of Polyethylene Glycol 3350-electrolyte Solution (GoLYTELY®) Versus Lactulose in Patients With Hepatic Encephalopathy. https://ClinicalTrials.gov/show/NCT01283152 Completed University of Texas Southwestern Medical Center 2012-06-30
NCT01271660 A Study Evaluating the Efficacy and Safety of Pregabalin Against Frequent Muscle Cramp in Patients With Liver Cirrhosis https://ClinicalTrials.gov/show/NCT01271660 Completed Seoul National University Boramae Hospital 2018-02-28
NCT02023229 Branched Chain Aminoacid Supplementation in Patients With Liver Cirrhosis https://ClinicalTrials.gov/show/NCT02023229 Completed Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 2013-01-31
NCT02041780 Non Invasive Assessment of Liver Fibrosis in Children: Comparison of ShearWave Elastography, Fibrotest and Liver Biopsy https://ClinicalTrials.gov/show/NCT02041780 Completed Assistance Publique - Hôpitaux de Paris 2016-05-31
NCT02028949 Treatment of Cirrhosis-related Hepatocellular Carcinoma With the Intrahepatic Arterial Injection of an Emulsion of Lipiodol and Idarubicin (Zavedos®): Phase I Study https://ClinicalTrials.gov/show/NCT02028949 Completed Centre Hospitalier Universitaire Dijon 2015-11-30
NCT02026401 Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis https://ClinicalTrials.gov/show/NCT02026401 Completed NGM Biopharmaceuticals, Inc 2014-12-31
NCT02019784 Randomised Controlled Trial of Mechanistic Effects of Rifaximin in Cirrhosis and Chronic Hepatic Encephalopathy https://ClinicalTrials.gov/show/NCT02019784 Completed King’s College Hospital NHS Trust 2016-06-30
NCT04065841 Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin Compared to Each Monotherapy, in Adult Patients With NASH and Liver Fibrosis. https://ClinicalTrials.gov/show/NCT04065841 Recruiting Novartis 2022-03-15
NCT01951209 Pilot Study Of The Effect Of Rifaximin On B-Cell Dysregulation In Cirrhosis https://ClinicalTrials.gov/show/NCT01951209 Active, not recruiting Corporal Michael J. Crescenz VA Medical Center 2018-08-31
NCT01943617 Optimized Treatment and Regression of HBV-induced Compensated Liver Cirrhosis https://ClinicalTrials.gov/show/NCT01943617 Completed Beijing Friendship Hospital 2016-12-31
NCT01938820 Optimized Treatment and Regression of HBV-induced Early Cirrhosis https://ClinicalTrials.gov/show/NCT01938820 Completed Beijing Friendship Hospital 2016-12-31
NCT01938781 Optimized Treatment and Regression of HBV-induced Liver Fibrosis https://ClinicalTrials.gov/show/NCT01938781 Completed Beijing Friendship Hospital 2016-12-31
NCT01935817 Silybin - Vitamin E- Phospholipids Complex Reduces Liver Fibrosis in Patients With Chronic Hepatitis C Treated With Peg-IFN-a and RBV https://ClinicalTrials.gov/show/NCT01935817 Completed University of Catania 2012-12-31
NCT01934777 Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT01934777 Completed Bambino Gesù Hospital and Research Institute 2014-10-31
NCT01909778 Open Label Single Dose Phase I Trial of BI 201335 to Study Pharmacokinetics and Safety in Patients With Compensated Liver Cirrhosis https://ClinicalTrials.gov/show/NCT01909778 Completed Boehringer Ingelheim 2008-10-31
NCT01905254 Transient Elastography in Autoimmune Hepatitis https://ClinicalTrials.gov/show/NCT01905254 Completed Universitätsklinikum Hamburg-Eppendorf 2010-08-31
NCT01904409 Dose-ranging Study of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications of Early Decompensated Liver Cirrhosis https://ClinicalTrials.gov/show/NCT01904409 Completed Bausch Health Americas, Inc. 2015-06-30
NCT01904058 Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis https://ClinicalTrials.gov/show/NCT01904058 Completed Mirum Pharmaceuticals, Inc. 2015-04-30
NCT01902511 A Trial to Study the Influence of Growth Factors on Bone Marrow and Hepatic Regeneration in Patients With Decompensated Cirrhosis. https://ClinicalTrials.gov/show/NCT01902511 Completed Institute of Liver and Biliary Sciences, India 2015-12-31
NCT01899703 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus https://ClinicalTrials.gov/show/NCT01899703 Completed GlaxoSmithKline 2015-10-07
NCT01888900 New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis C https://ClinicalTrials.gov/show/NCT01888900 Completed National Institutes of Health Clinical Center (CC) 2015-11-30
NCT01884415 Phase III, Study to Evaluate the Efficacy of Two Different HBV Vaccination Schemes in Patients With Hepatic Cirrhosis https://ClinicalTrials.gov/show/NCT01884415 Completed Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 2017-12-31
NCT01875081 REVIVE(Randomized Exploratory Clinical Trial to Evaluate the Safety and Effectiveness of Stem Cell Product in Alcoholic Liver Cirrhosis Patient) https://ClinicalTrials.gov/show/NCT01875081 Completed Pharmicell Co., Ltd. 2016-03-31
NCT01865812 Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Subjects With Primary Biliary Cirrhosis https://ClinicalTrials.gov/show/NCT01865812 Completed Intercept Pharmaceuticals 2014-08-31
NCT01857284 Safety and Efficacy of Tauroursodeoxycholic Acid Versus Ursofalk in the Treatment of Adult Primary Biliary Cirrhosis https://ClinicalTrials.gov/show/NCT01857284 Completed Beijing Friendship Hospital 2013-01-31
NCT01836224 Efficacy and Safety of Monotherapy With Noradrenaline and Terlipressin in Patients of Cirrhosis With Septic Shock Admitted to Intensive Care Unit https://ClinicalTrials.gov/show/NCT01836224 Completed Institute of Liver and Biliary Sciences, India 2014-09-30
NCT01804829 Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients. https://ClinicalTrials.gov/show/NCT01804829 Completed Biotest Pharmaceuticals Corporation 2016-02-29
NCT01799785 Effects of Aerobic Training on Exercise Capacity in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT01799785 Completed University of Alberta 2013-07-31
NCT01789008 Transient Elastography in the Determination of Advanced Fibrosis in Alcoholic Liver Disease. https://ClinicalTrials.gov/show/NCT01789008 Completed Rennes University Hospital 2017-06-19
NCT01781208 Ultrasound Based Acoustic Radiation Force Impulse Imaging https://ClinicalTrials.gov/show/NCT01781208 Completed University of Michigan 2015-05-31
NCT01773538 Diagnosis of Covert/Minimal Hepatic Encephalopathy by Means of Continuous Reaction Time Measurement https://ClinicalTrials.gov/show/NCT01773538 Completed Hospital of South West Jutland 2015-10-31
NCT01769040 Intestinal Decontamination With Rifaximin. The Inflammatory and Circulatory State in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT01769040 Completed Copenhagen University Hospital, Hvidovre 2016-01-31
NCT01767597 Application of HBV Rapid Tests as a Tool for Wide-Use Screening https://ClinicalTrials.gov/show/NCT01767597 Completed Institut de Médecine et d’Epidémiologie Appliquée - Fondation Internationale Léon M’Ba 2012-07-31
NCT01762748 Effect of Saccharomyces Boulardii in Patients in the Waiting List for Liver Transplant https://ClinicalTrials.gov/show/NCT01762748 Completed Federal University of Minas Gerais 2012-12-31
NCT01747772 Sonoelastography: Ultrasound Method to Measure Liver Fibrosis https://ClinicalTrials.gov/show/NCT01747772 Completed Massachusetts General Hospital 2014-02-14
NCT01735591 Administration of Probiotics in Cirrhotic Patients Listed for Liver Transplantation https://ClinicalTrials.gov/show/NCT01735591 Completed Medical University of Warsaw 2015-11-30
NCT01722578 L-ornithine L-aspartate in Overt Hepatic Encephalopathy https://ClinicalTrials.gov/show/NCT01722578 Completed Dayanand Medical College and Hospital 2017-01-31
NCT01713478 Subclinical Myocardial Dysfunction in Patients With Hepatic Cirrhosis https://ClinicalTrials.gov/show/NCT01713478 Completed Carol Davila University of Medicine and Pharmacy 2014-12-31
NCT01707472 Study of Simtuzumab in HIV and/or Hepatitis C- Infected Adults With Liver Fibrosis https://ClinicalTrials.gov/show/NCT01707472 Completed Gilead Sciences 2014-10-17
NCT01704755 A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267; (ABT-267 Also Known as Ombitasvir) and ABT-333 (Also Known as Dasabuvir) Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis https://ClinicalTrials.gov/show/NCT01704755 Completed AbbVie 2014-01-31
NCT01687257 Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation https://ClinicalTrials.gov/show/NCT01687257 Completed Gilead Sciences 2015-01-31
NCT01686698 Effect of VSL#3 (Original De Simone Formulation) on Cognitive Function, Risk of Falls and Quality of Life in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT01686698 Completed Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau 2014-03-31
NCT01676285 Metoprolol Succinate in Cardiac Remodeling Related to Cirrhosis https://ClinicalTrials.gov/show/NCT01676285 Completed University of Sao Paulo 2013-09-30
NCT01640964 An Exploratory Haemodynamic Study in Patients With Compensated Cirrhosis and Portal Hypertension https://ClinicalTrials.gov/show/NCT01640964 Completed Novartis 2014-12-31
NCT01618890 Hepatic Venous Pressure Gradient-guided Versus Standard Beta-blocker Therapy in Primary Prevention of Variceal Bleeding https://ClinicalTrials.gov/show/NCT01618890 Recruiting Leiden University Medical Center 2020-12-31
NCT01614405 Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis https://ClinicalTrials.gov/show/NCT01614405 Completed University of Alberta 2015-07-31
NCT01607528 Influence of Probiotics on Infections in Cirrhosis https://ClinicalTrials.gov/show/NCT01607528 Completed Medical University of Graz 2014-03-31
NCT01603199 High-protein High-fiber Diet in Patients With Primary Biliary Cirrhosis https://ClinicalTrials.gov/show/NCT01603199 Completed Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 2015-07-31
NCT01600105 Detection of Liver Fibrosis With Magnetic Resonance Imaging (MRI) https://ClinicalTrials.gov/show/NCT01600105 Completed Icahn School of Medicine at Mount Sinai 2017-07-31
NCT01598064 Probiotics for Liver Cirrhosis With Portal Hypertension https://ClinicalTrials.gov/show/NCT01598064 Completed National Cheng-Kung University Hospital 2013-08-31
NCT01591200 Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis https://ClinicalTrials.gov/show/NCT01591200 Completed Stempeutics Research Pvt Ltd 2016-04-30
NCT01575574 Magnetic Resonance With Gadoxetic Acid for the Diagnosis of Hepatocellular Carcinoma in Patients With Liver Cirrhosis. Evaluation of Its Impact for the Non-invasive Diagnosis https://ClinicalTrials.gov/show/NCT01575574 Completed Fundacion Clinic per a la Recerca Biomédica 2016-07-31
NCT01572064 Magnetic Resonance Imaging in the Evaluation of Liver Fibrosis https://ClinicalTrials.gov/show/NCT01572064 Completed University of Nottingham 2012-09-30
NCT01556646 Effect of Tolvaptan on Cognitive Function in Cirrhosis https://ClinicalTrials.gov/show/NCT01556646 Completed Hunter Holmes Mcguire Veteran Affairs Medical Center 2013-06-30
NCT04321031 Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA) https://ClinicalTrials.gov/show/NCT04321031 Recruiting Pfizer 2022-11-01
NCT01537965 Evaluation of Innovative Ultrasonic Techniques for Non-invasive Diagnosis of Liver Fibrosis in Patients With Chronic Viral Hepatitis B or C https://ClinicalTrials.gov/show/NCT01537965 Completed University Hospital, Grenoble 2014-01-31
NCT01510860 Ursofalk Tablets (500 mg) Versus Ursofalk Capsules (250 mg) in the Treatment of Primary Biliary Cirrhosis https://ClinicalTrials.gov/show/NCT01510860 Completed Dr. Falk Pharma GmbH 2010-07-31
NCT01509391 Keyhole Limpet Hemocyanin in Chronic Hepatitis C https://ClinicalTrials.gov/show/NCT01509391 Completed Medical University of Graz 2012-10-31
NCT01503749 Safety and Efficacy Study of Peripheral Blood Mononucleated Cells for Treatment of Liver Cirrhosis https://ClinicalTrials.gov/show/NCT01503749 Completed Seoul National University Hospital 2013-07-31
NCT01495403 Treatment of Muscle Cramps in Patients With Liver Cirrhosis https://ClinicalTrials.gov/show/NCT01495403 Completed Mayo Clinic 2015-04-30
NCT01473524 Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis https://ClinicalTrials.gov/show/NCT01473524 Completed Intercept Pharmaceuticals 2013-12-31
NCT01463956 Efficacy of PegInterferon-Ribavirin-Boceprevir Therapy in Patients Infected With G1 HCV With Cirrhosis, Awaiting Liver Transplantation https://ClinicalTrials.gov/show/NCT01463956 Completed French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) 2014-06-30
NCT01463735 Vitamin E Supplement in Patients With Cirrhosis and Acanthocytosis https://ClinicalTrials.gov/show/NCT01463735 Completed University Hospital, Geneva 2013-05-31
NCT01458990 Proton Pump Inhibitors and Dysbiosis in Cirrhosis https://ClinicalTrials.gov/show/NCT01458990 Completed Hunter Holmes Mcguire Veteran Affairs Medical Center 2018-02-28
NCT00006168 Ursodiol-Methotrexate for Primary Biliary Cirrhosis https://ClinicalTrials.gov/show/NCT00006168 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NA
NCT01456286 Randomized Controlled Trial to Assess the Effects of Sapropterin on Hepatic and Systemic Hemodynamics in Patients With Liver Cirrhosis and Portal Hypertension https://ClinicalTrials.gov/show/NCT01456286 Completed Fundacion Clinic per a la Recerca Biomédica 2013-10-31
NCT01454336 Transplantation of Autologous Mesenchymal Stem Cell in Decompensate Cirrhotic Patients With Pioglitazone https://ClinicalTrials.gov/show/NCT01454336 Completed Royan Institute 2013-07-31
NCT01452308 Pilot Study of Simtuzumab in the Treatment of Liver Fibrosis https://ClinicalTrials.gov/show/NCT01452308 Completed Gilead Sciences 2013-01-31
NCT01447667 Magnetic Resonance Elastography (MRE) as a Predictor of HCC Recurrence After Radiofrequency Ablation (RFA) https://ClinicalTrials.gov/show/NCT01447667 Recruiting Seoul National University Hospital 2021-12-31
NCT01447537 Mechanisms Involved in the Benefits of an Exercise Programme in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT01447537 Completed Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau 2012-06-30
NCT01434108 Effects of the Administration of Ornithine Phenylacetate in Patients With Cirrhosis and Upper Gastrointestinal Bleeding https://ClinicalTrials.gov/show/NCT01434108 Completed Hospital Universitari Vall d’Hebron Research Institute 2015-03-31
NCT01409356 Effects of Weight Loss on Portal Pressure in Patients With Overweight/Obesity and Cirrhosis https://ClinicalTrials.gov/show/NCT01409356 Completed Hospital Clinic of Barcelona 2014-02-28
NCT01408966 Effects of Dark vs. White Chocolate on the Postprandial Increase in Portal Pressure in Cirrhosis https://ClinicalTrials.gov/show/NCT01408966 Completed Hospital Clinic of Barcelona 2008-10-31
NCT01389973 A Study of Efficacy and Safety of Ustekinumab in Patients With Primary Biliary Cirrhosis (PBC) Who Had an Inadequate Response to Ursodeoxycholic Acid https://ClinicalTrials.gov/show/NCT01389973 Completed Janssen Research & Development, LLC 2013-06-30
NCT01387061 Resection for Multiple Hepatocellular Carcinomas (HCC) https://ClinicalTrials.gov/show/NCT01387061 Completed University of Milan 2011-06-30
NCT01379469 Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency https://ClinicalTrials.gov/show/NCT01379469 Recruiting Washington University School of Medicine 2021-01-31
NCT01370161 Early TIPS With Polytetrafluoroethylene (PTFE) Covered Stents for Acute Variceal Bleeding in Patients With Advanced Cirrhosis https://ClinicalTrials.gov/show/NCT01370161 Completed Fourth Military Medical University 2018-09-30
NCT01359462 Multiple-dose Pharmacokinetics Study of Tolvaptan Tablets in Chinese Patients With Hepatocirrhosis https://ClinicalTrials.gov/show/NCT01359462 Completed Otsuka Beijing Research Institute 2009-11-30
NCT01349348 Phase III Study of Tolvaptan Tablet to Treat Cirrhosis Ascites https://ClinicalTrials.gov/show/NCT01349348 Completed Otsuka Beijing Research Institute 2012-05-31
NCT01342250 Human Umbilical Cord Mesenchymal Stem Cells Transplantation for Patients With Decompensated Liver Cirrhosis https://ClinicalTrials.gov/show/NCT01342250 Completed Shenzhen Beike Bio-Technology Co., Ltd. 2011-07-31
NCT01333228 Evaluate Safety and Efficacy of Autologous Bone Marrow-derived Endothelial Progenitor Cells in Advanced Liver Cirrhosis https://ClinicalTrials.gov/show/NCT01333228 Completed Clinica Universidad de Navarra, Universidad de Navarra 2014-10-31
NCT04421924 Periinterventional Coagulation Management of Patients Undergoing a TIPS https://ClinicalTrials.gov/show/NCT04421924 Recruiting Medical University of Graz 2022-05-31
NCT04414956 Combining Biomarkers (AFP, AFP-L3, and PIVKA-II) and Image Tools for Early Detection of Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT04414956 Recruiting Korea University 2023-06-30
NCT04399512 Oral Health Status in Patients With Cirrhosis and Effect of Dental Treatment on MELD Score of Cirrhosis Patients https://ClinicalTrials.gov/show/NCT04399512 Recruiting Postgraduate Institute of Dental Sciences Rohtak 2021-04-30
NCT04397289 Anticoagulation Therapy After Splenectomy in Cirrhosis Patient https://ClinicalTrials.gov/show/NCT04397289 Recruiting First Affiliated Hospital Xi’an Jiaotong University 2021-03-31
NCT04383951 Safety and Efficacy of Ketogenic Diet for Promoting Weight Loss in Obese Individuals With Compensated NASH Cirrhosis https://ClinicalTrials.gov/show/NCT04383951 Recruiting Indiana University 2024-12-31
NCT04358016 Terlipression Prevent Developing of Acute Kidney Injury During Upper-gastroentestinal Bleeding https://ClinicalTrials.gov/show/NCT04358016 Completed Changhai Hospital 2020-01-01
NCT04322201 Continuous Passive Paracentesis for Intra-abdominal Hypertension https://ClinicalTrials.gov/show/NCT04322201 Recruiting Centro Hospitalar de Lisboa Central 2021-11-30
NCT04288323 Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT04288323 Recruiting University of California, San Diego 2021-12-31
NCT04281784 Project to Improve Communication About Serious Illness–Hospital Study: Pragmatic Trial (Trial 1) https://ClinicalTrials.gov/show/NCT04281784 Recruiting University of Washington 2021-09-01
NCT04252794 Graft Inflow Modulation for Portal Hyper-perfusion in Live Donor Liver Transplantation https://ClinicalTrials.gov/show/NCT04252794 Enrolling by invitation Institute of Liver and Biliary Sciences, India 2021-01-31
NCT04243681 Combination of Autologous MSC and HSC Infusion in Patients With Decompensated Cirrhosis https://ClinicalTrials.gov/show/NCT04243681 Recruiting Asian Institute of Gastroenterology, India 2020-06-01
NCT04216784 Comparison of Diuretic Effect With Furosemide Alone Versus the Combination of Furosemide and Albumin in Cirrhotic Patients https://ClinicalTrials.gov/show/NCT04216784 Recruiting Rush University Medical Center 2020-11-30
NCT04212286 Comparing the Diagnostic Efficiencies of CEUS and EOB-MRI in Patients With High Risk of HCC https://ClinicalTrials.gov/show/NCT04212286 Recruiting Tianjin Third Central Hospital 2021-12-31
NCT04212273 Diagnostic Efficacies of Sonazoid-CEUS and EOB-MRI in Patients With High Risk of HCC https://ClinicalTrials.gov/show/NCT04212273 Recruiting Tianjin Third Central Hospital 2021-12-24
NCT04205396 CAREGIVER: A Trial to Improve the Burden and Distress of Caring for Persons With Decompensated Cirrhosis https://ClinicalTrials.gov/show/NCT04205396 Recruiting University of Michigan 2022-12-31
NCT04196998 Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Hepatitis b Virus Related Compensated Cirrhosis https://ClinicalTrials.gov/show/NCT04196998 Recruiting Third Affiliated Hospital, Sun Yat-Sen University 2023-12-31
NCT04195971 Dual Arterial Phase Liver CT in Patients With Suspected Portal Hypertension https://ClinicalTrials.gov/show/NCT04195971 Recruiting Seoul National University Hospital 2020-12-31
NCT04191369 EGD vs EUS in Diagnosing Portal Hypertension in Cirrhotic Patients. https://ClinicalTrials.gov/show/NCT04191369 Recruiting Instituto Ecuatoriano de Enfermedades Digestivas 2020-11-01
NCT04160039 Early Cycle Ergometry for Critically-Ill Liver Failure Patients in a Transplant Intensive Care Unit https://ClinicalTrials.gov/show/NCT04160039 Recruiting Medical College of Wisconsin 2020-12-31
NCT04149223 Cirrhosis Care Alberta (CCAB): A Pragmatic Type II Hybrid Effectiveness Implementation Trial https://ClinicalTrials.gov/show/NCT04149223 Recruiting University of Alberta 2021-06-01
NCT04140578 Antibiotic Prophylaxis in Patients Undergoing GVO https://ClinicalTrials.gov/show/NCT04140578 Recruiting Taipei Veterans General Hospital, Taiwan 2030-12-31
NCT04113629 Simplified Monitoring Myanmar SM2 Study https://ClinicalTrials.gov/show/NCT04113629 Recruiting Kirby Institute 2020-12-22
NCT04111133 Ivabradine in Cirrhotic Cardiomyopathy https://ClinicalTrials.gov/show/NCT04111133 Recruiting Postgraduate Institute of Medical Education and Research 2021-10-31
NCT04099407 Pirfenidone and Advanced Liver Fibrosis. https://ClinicalTrials.gov/show/NCT04099407 Recruiting Grupo Mexicano para el Estudios de las Enfermedades Hepaticas 2020-08-31
NCT04089878 "To Study the Impact of Balloon-occluded Retrograde Transvenous Obliteration (BRTO)/Plug Assisted Retrograde Transvenous Obliteration (PARTO) Mediated Portal Flow Modulation in Reduction of Ammonia and Improvement in Organ Volume and Functionality in Patients of Cirrhosis With LR Shunt https://ClinicalTrials.gov/show/NCT04089878 Recruiting Institute of Liver and Biliary Sciences, India 2020-09-30
NCT04088058 A Phase II Open-label Single-arm Study to Evaluate the Efficacy and Safety of ADSCs in Subjects With Liver Cirrhosis https://ClinicalTrials.gov/show/NCT04088058 Recruiting Gwo Xi Stem Cell Applied Technology Co., Ltd. 2021-10-31
NCT04082780 Rifamycin in Minimal Hepatic Encephalopathy https://ClinicalTrials.gov/show/NCT04082780 Recruiting Hunter Holmes Mcguire Veteran Affairs Medical Center 2020-09-15
NCT04073290 Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose https://ClinicalTrials.gov/show/NCT04073290 Recruiting Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2022-09-30
NCT04072601 Statins for Prevention of Disease Progression and Hospitalization in Liver Cirrhosis https://ClinicalTrials.gov/show/NCT04072601 Recruiting Copenhagen University Hospital, Hvidovre 2022-12-31
NCT04058613 Effects of Maintaining Steady Albumin Levels (TAT 4) on Survival and Liver Related Complications in Cirrhosis With Ascites https://ClinicalTrials.gov/show/NCT04058613 Recruiting Institute of Liver and Biliary Sciences, India 2020-08-08
NCT04048876 Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Non-alcoholic Steatohepatitis (NASH) and Stage 3 or Stage 4 Liver Fibrosis https://ClinicalTrials.gov/show/NCT04048876 Recruiting Celgene 2022-07-06
NCT04047160 Safety, Tolerability of OP-724 in Patients With Primary Biliary Cholangitis (Phase I) https://ClinicalTrials.gov/show/NCT04047160 Recruiting Komagome Hospital 2021-03-31
NCT04041115 Effect of Non-alcoholic Beer in Cirrhosis https://ClinicalTrials.gov/show/NCT04041115 Active, not recruiting Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 2018-12-31
NCT04013074 Efficacy and Safety of Early TIPS (Transjugular Intrahepatic Portosystemic Shunts) in the Management of Cirrhosis With Recurrent Ascites. https://ClinicalTrials.gov/show/NCT04013074 Recruiting Institute of Liver and Biliary Sciences, India 2020-07-31
NCT04012021 EXplanted LIver and Ex-vivo Pancreatic Specimen Evaluation by 7 TESLA MRI https://ClinicalTrials.gov/show/NCT04012021 Recruiting University of Pisa 2020-01-31
NCT03995251 Efficacy and Safety of Testosterone Therapy in Improving Sarcopenia in Men With Cirrhosis. https://ClinicalTrials.gov/show/NCT03995251 Recruiting Institute of Liver and Biliary Sciences, India 2020-06-30
NCT03175731 PPIs and Gastroesophageal Varices in Liver Cirrhosis (PPIs: Proton Pump Inhibitors) https://ClinicalTrials.gov/show/NCT03175731 Completed Qilu Hospital of Shandong University 2019-08-30
NCT03969186 Telehealth Intervention in Cirrhotics https://ClinicalTrials.gov/show/NCT03969186 Active, not recruiting University of Pennsylvania 2020-07-31
NCT03969017 Combination Treatment of NAs and Peg IFN α-2b for Hepatitis B Related, Compensatory Cirrhosis Patients https://ClinicalTrials.gov/show/NCT03969017 Recruiting Sun Yat-sen University 2022-05-30
NCT03957629 Optimized Treatment of Peginterferon Alfa 2a in Treatment Experienced Patients With HBV Related Liver Fibrosis https://ClinicalTrials.gov/show/NCT03957629 Recruiting Third Affiliated Hospital, Sun Yat-Sen University 2021-07-30
NCT03945487 Mesenchymal Stem Cells Treatment for Decompensated Liver Cirrhosis https://ClinicalTrials.gov/show/NCT03945487 Recruiting Beijing 302 Hospital 2021-12-30
NCT03932552 Effects of a Novel Physical Exercise Program in Patients With Cirrhosis (the LFN-exercise Protocol) https://ClinicalTrials.gov/show/NCT03932552 Active, not recruiting Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 2018-12-31
NCT03920605 Optimized Treatment of Peginterferon Alfa 2a/2b in Treatment Experienced Patients With HBV Related Liver Fibrosis https://ClinicalTrials.gov/show/NCT03920605 Recruiting Third Affiliated Hospital, Sun Yat-Sen University 2021-10-30
NCT03919565 Optimized Treatment of Peginterferon Alfa 2a/2b in Anti-virus Treatment Naive Patients With HBV Related Liver Fibrosis https://ClinicalTrials.gov/show/NCT03919565 Recruiting Third Affiliated Hospital, Sun Yat-Sen University 2021-10-31
NCT03911037 GCSF Therapy in Decompensated Cirrhosis - A Double Blinded RCT https://ClinicalTrials.gov/show/NCT03911037 Recruiting Postgraduate Institute of Medical Education and Research 2020-06-30
NCT03892070 Beta-Hydroxy-Beta-Methylbutyrate Supplementation and Physical Activity in Liver Cirrhosis: a Controlled Trial https://ClinicalTrials.gov/show/NCT03892070 Recruiting University of Roma La Sapienza 2019-12-10
NCT03868397 Preoperative Portal and Splanchnic Flow Measurement Using MRI https://ClinicalTrials.gov/show/NCT03868397 Active, not recruiting Seoul National University Hospital 2020-08-31
NCT03864276 The Comparison of Changes of QTc, Tp-e Interval, and Tp-e/QT Ratio, Tp-e/QTc Ratio on the ECG During Living Donor Liver Transplantation Under Desflurane and Total Intravenous Anesthesia -Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT03864276 Recruiting Yonsei University 2020-10-31
NCT03863730 Profermin®: Prevention of Progression in Alcoholic Liver Disease by Modulating Dysbiotic Microbiota https://ClinicalTrials.gov/show/NCT03863730 Recruiting Odense University Hospital 2021-07-31
NCT03855956 Clinical Food Study to Evaluate the Effect of KB174 on the Gut Microbiome in Subjects With Well-compensated Cirrhosis https://ClinicalTrials.gov/show/NCT03855956 Completed Kaleido Biosciences 2019-10-01
NCT03846843 OCR002-SP103 - Oral Immediate Release Study https://ClinicalTrials.gov/show/NCT03846843 Completed Mallinckrodt 2017-11-30
NCT03838250 Study to Evaluate Hepatic Artery Injection of Autologous Human Bone Marrow-Derived MSCs in Patients With Alcoholic LC https://ClinicalTrials.gov/show/NCT03838250 Recruiting Pharmicell Co., Ltd. 2021-03-31
NCT03827681 To Study the Efficacy and Safety of TIPS (Trans Intrahepatic Portosystemic Shunt) Versus Self Expanding Metallic Stent (SEMS) in the Management of Refractory Variceal Bleed in Cirrhotics. https://ClinicalTrials.gov/show/NCT03827681 Recruiting Institute of Liver and Biliary Sciences, India 2020-06-30
NCT03827200 A Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver Cirrhosis https://ClinicalTrials.gov/show/NCT03827200 Recruiting Noorik Biopharmaceuticals AG 2020-09-30
NCT03809052 A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GB1211 in Healthy Subjects and in Subjects With Suspected Non-Alcoholic Steato-Hepatitis (NASH) and Liver Fibrosis https://ClinicalTrials.gov/show/NCT03809052 Recruiting Galecto Biotech AB 2020-01-31
NCT03798119 TAF Switch in F3/4 CHB pt With Partial Response to NUC (ESTAB-AFPVR) https://ClinicalTrials.gov/show/NCT03798119 Recruiting Kaohsiung Medical University Chung-Ho Memorial Hospital 2020-08-31
NCT03796598 FMT in Cirrhosis and Hepatic Encephalopathy https://ClinicalTrials.gov/show/NCT03796598 Recruiting VA Office of Research and Development 2023-06-01
NCT03780673 Efficacy of the Combination of Simvastatin Plus Rifaximin in Patients With Decompensated Cirrhosis to Prevent ACLF Development https://ClinicalTrials.gov/show/NCT03780673 Recruiting Institut d’Investigacions Biomèdiques August Pi i Sunyer 2021-12-31
NCT03776955 Beta-blockers for Oesophageal Varices https://ClinicalTrials.gov/show/NCT03776955 Recruiting King’s College Hospital NHS Trust 2024-09-30
NCT03759158 N-Acetyl Cysteine in the Prevention of Contrast Induced Nephropathy in Cirrhosis of Liver-NEPHRO Trial https://ClinicalTrials.gov/show/NCT03759158 Completed Institute of Liver and Biliary Sciences, India 2019-01-15
NCT03748563 DS-MCE vs EGD for Diagnosing Gastroesophageal Varices https://ClinicalTrials.gov/show/NCT03748563 Recruiting Changhai Hospital 2019-12-31
NCT03736265 Carvedilol for Prevention of Esophageal Varices Progression https://ClinicalTrials.gov/show/NCT03736265 Recruiting Beijing Friendship Hospital 2020-12-30
NCT03725631 Non-invasive Evaluation of Liver Fibrosis, Steatosis, and NASH in NAFLD https://ClinicalTrials.gov/show/NCT03725631 Recruiting Korea University Guro Hospital 2019-08-31
NCT03721952 Facilitating Communication Study https://ClinicalTrials.gov/show/NCT03721952 Recruiting University of Washington 2022-10-31
NCT03712280 MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy) https://ClinicalTrials.gov/show/NCT03712280 Recruiting Mallinckrodt 2020-08-31
NCT03695705 Rifaximin and Norfloxacin for Prevention of SBP in Adults With Decompensated Cirrhosis https://ClinicalTrials.gov/show/NCT03695705 Completed Postgraduate Institute of Medical Education and Research 2016-12-31
NCT03694691 Developing Viability Index for Machine Perfused Livers https://ClinicalTrials.gov/show/NCT03694691 Recruiting Massachusetts General Hospital 2021-10-01
NCT03673215 The Tolerability,Safety,PK/PD Study of rhTPO in the Patients With Liver Function Impairment https://ClinicalTrials.gov/show/NCT03673215 Recruiting Shenyang Sunshine Pharmaceutical Co., LTD. 2020-10-08
NCT03659058 Impact of Ursodeoxycholic Acid, Silymarin, Antioxidants and Colchicine on Fibrosis Regression in HCV After SVR https://ClinicalTrials.gov/show/NCT03659058 Completed Zagazig University 2018-08-31
NCT03656068 An Evaluation of the Safety and Efficacy of NTZ on Collagen Turnover in NASH Patients With Fibrosis https://ClinicalTrials.gov/show/NCT03656068 Recruiting Pinnacle Clinical Research, PLLC 2019-12-31
NCT03637959 Liver Fibrosis Evaluation Using Ultrasound Shear Wave Imaging https://ClinicalTrials.gov/show/NCT03637959 Enrolling by invitation Mayo Clinic 2021-12-31
NCT03633279 Sarcopenia Improves the Muscle Mass and Muscle Strength of Patients With Liver Cirrhosis-Child C https://ClinicalTrials.gov/show/NCT03633279 Recruiting Dayanand Medical College and Hospital 2020-06-30
NCT03633227 Study of OCA Evaluating Pharmacokinetics and Safety in Patients With PBC and Hepatic Impairment https://ClinicalTrials.gov/show/NCT03633227 Recruiting Intercept Pharmaceuticals 2022-12-01
NCT03626090 Mesenchymal Stem Cell Therapy for Liver Cirrhosis https://ClinicalTrials.gov/show/NCT03626090 Recruiting Stem Med Pte. Ltd. 2020-10-22
NCT03625726 Rôle of the Soluble Endothelial Protein C Receptor in Cirrhosis-associated Hypercoagulability State (EXERCISE) https://ClinicalTrials.gov/show/NCT03625726 Recruiting University Hospital, Clermont-Ferrand 2020-08-31
NCT03624517 Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices https://ClinicalTrials.gov/show/NCT03624517 Recruiting Medical University of South Carolina 2020-12-31
NCT03620474 Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis https://ClinicalTrials.gov/show/NCT03620474 Recruiting Komagome Hospital 2020-11-30
NCT03612973 Changes in Liver Fibrosis, Lipid Profile and Insulin Resistance in HCV Patients Who Received Antiviral Therapy https://ClinicalTrials.gov/show/NCT03612973 Recruiting Assiut University 2021-10-31
NCT03605147 The Effect of Calcium β-hydroxy-β-methylbutyrate (CaHMB) Supplementation in Sarcopenia in Liver Cirrhosis https://ClinicalTrials.gov/show/NCT03605147 Recruiting Shanghai Zhongshan Hospital 2019-07-31
NCT03568578 A Study in Reversing Hepatic Fibrosis or Cirrhosis Related to Hepatitis B Virus and Finding Biomarkers https://ClinicalTrials.gov/show/NCT03568578 Recruiting Peking University First Hospital 2020-12-31
NCT03566914 Tadalafil for Erectile Dysfunction in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT03566914 Recruiting Institute of Liver and Biliary Sciences, India 2020-06-30
NCT03564626 Health IT Generated PROs to Improve Outcomes in Cirrhosis https://ClinicalTrials.gov/show/NCT03564626 Enrolling by invitation Virginia Commonwealth University 2022-06-20
NCT03559166 First in Human Study in Healthy Volunteers Followed With Dosing in Participants With Lung or Liver Fibrosis https://ClinicalTrials.gov/show/NCT03559166 Completed Blade Therapeutics 2019-10-04
NCT03547895 Management of Decompensated HCV Cirrhotic Patients https://ClinicalTrials.gov/show/NCT03547895 Completed Zagazig University 2016-05-24
NCT03534141 Mild Hypothermia and Acute Kidney Injury in Liver Transplantation https://ClinicalTrials.gov/show/NCT03534141 Recruiting University of California, San Francisco 2020-06-30
NCT03517540 Safety, Tolerability, and Efficacy of a Combination Treatment of Tropifexor (LJN452) and Cenicriviroc (CVC) in Adult Patients With Nonalcoholic Steatohepatitis (NASH) and Liver Fibrosis. (TANDEM) https://ClinicalTrials.gov/show/NCT03517540 Recruiting Novartis 2020-08-28
NCT03493204 Tackling 30-day Readmissions in Patients With Cirrhosis: The SALTYFOOD Trial https://ClinicalTrials.gov/show/NCT03493204 Completed University of Michigan 2019-08-19
NCT03486912 A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis https://ClinicalTrials.gov/show/NCT03486912 Active, not recruiting Bristol-Myers Squibb 2020-09-17
NCT03486899 A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis https://ClinicalTrials.gov/show/NCT03486899 Active, not recruiting Bristol-Myers Squibb 2020-04-28
NCT03470389 Establishment and Assessment of the HVPG Using Biofluid Mechanics (HVPGBFM) https://ClinicalTrials.gov/show/NCT03470389 Recruiting Shanghai Ninth People’s Hospital Affiliated to Shanghai Jiao Tong University 2020-09-30
NCT03451292 Effects of Long-Term Administration of Human Albumin in Subjects With Decompensated Cirrhosis and Ascites https://ClinicalTrials.gov/show/NCT03451292 Recruiting Grifols Therapeutics LLC 2021-10-31
NCT03447730 Safety, Tolerability and Pharmacodynamics of SYNB1020 https://ClinicalTrials.gov/show/NCT03447730 Completed Synlogic 2019-08-20
NCT03445208 A Study of Experimental Medication BMS-986036 Given to Healthy Participants https://ClinicalTrials.gov/show/NCT03445208 Completed Bristol-Myers Squibb 2018-05-02
NCT03439254 Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT03439254 Active, not recruiting Intercept Pharmaceuticals 2021-06-30
NCT03437876 Study on Effect of Intestinal Microbiota Transplantation in Hepatitis B Virus Induced Cirrhosis https://ClinicalTrials.gov/show/NCT03437876 Recruiting Zhongshan Hospital Xiamen University 2020-11-30
NCT03420768 A Study of Experimental Medication BMS-986263 in Adults With Advanced Hepatic Fibrosis After Cure of Hepatitis C https://ClinicalTrials.gov/show/NCT03420768 Completed Bristol-Myers Squibb 2018-12-10
NCT03416751 Fecal Microbial Transplant for Alcohol Misuse in Cirrhosis https://ClinicalTrials.gov/show/NCT03416751 Completed Hunter Holmes Mcguire Veteran Affairs Medical Center 2020-04-10
NCT01265173 Comparison of Efficacy of Cefotaxime, Ceftriaxone, and Ciprofloxacin for the Treatment of SBP in Patients With LC https://ClinicalTrials.gov/show/NCT01265173 Completed Korea University 2018-06-30
NCT01249092 Pentoxifylline for Primary Biliary Cirrhosis https://ClinicalTrials.gov/show/NCT01249092 Completed The Cleveland Clinic 2012-06-30
NCT00006166 North American Study for the Treatment of Refractory Ascites (NASTRA) https://ClinicalTrials.gov/show/NCT00006166 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NA
NCT01231685 Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infection https://ClinicalTrials.gov/show/NCT01231685 Completed McGill University Health Centre/Research Institute of the McGill University Health Centre 2016-03-31
NCT01220492 Umbilical Cord Mesenchymal Stem Cells for Patients With Liver Cirrhosis https://ClinicalTrials.gov/show/NCT01220492 Completed Beijing 302 Hospital 2016-04-30
NCT01212250 Carvedilol for Pre-primary Prophylaxis of Esophageal Varices in Cirrhosis https://ClinicalTrials.gov/show/NCT01212250 Recruiting Institute of Liver and Biliary Sciences, India 2020-12-01
NCT01201720 Effects on Plasma Exchange on Functional Capacity of Serum Albumin, Circulatory Dysfunction, Renal and Cerebral Function in Cirrhotic Patients With “Acute-on-chronic Liver Failure” https://ClinicalTrials.gov/show/NCT01201720 Completed Grifols Therapeutics LLC 2013-01-31
NCT01196507 Early Primary Prophylaxis of Esophageal Varices https://ClinicalTrials.gov/show/NCT01196507 Completed Institute of Liver and Biliary Sciences, India 2014-04-30
NCT01165073 Short Term Feeding for Asian Patients With Liver Cirrhosis https://ClinicalTrials.gov/show/NCT01165073 Completed University of Malaya 2009-05-31
NCT03872024 Performances Evaluation of New FibroScan Probes Dedicated to Morbidly Obese Patients https://ClinicalTrials.gov/show/NCT03872024 Recruiting Echosens 2020-12-31
NCT01157845 Use of Methacetin Breath Test to Predict Liver Failure in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT01157845 Completed Virginia Commonwealth University 2012-07-31
NCT01150916 B-type Natriuretic Peptide in the Diagnosis of Heart Failure Related Ascites https://ClinicalTrials.gov/show/NCT01150916 Completed University of Sao Paulo 2011-11-30
NCT01147380 Safety Study of Liver Natural Killer Cell Therapy for Hepatoma Liver Transplantation https://ClinicalTrials.gov/show/NCT01147380 Completed University of Miami 2014-12-31
NCT01135628 Hyperproteic Diet Plus Lactobacillus Reuteri and Nitazoxanide in Minimal Hepatic Encephalopathy https://ClinicalTrials.gov/show/NCT01135628 Completed Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 2014-05-31
NCT01133795 Midodrine and Albumin for Cirrhotic Patients With Functional Renal Impairment https://ClinicalTrials.gov/show/NCT01133795 Completed Hospital Clinic of Barcelona 2016-06-30
NCT01120925 Autologous Bone Marrow Derived Stem Cells in Decompensate Cirrhotic Patients https://ClinicalTrials.gov/show/NCT01120925 Completed Royan Institute 2013-07-31
NCT01113814 Acoustic Radiation Force Impulse-Imaging in Comparison to Transient Elastography for Liver Fibrosis Staging in HCV https://ClinicalTrials.gov/show/NCT01113814 Completed Johann Wolfgang Goethe University Hospital NA
NCT01095185 Efficacy of Statin Association With Standard Treatment in Prevention of Recurrent Hemorrhage in Patient With Cirrhosis and Variceal Bleeding https://ClinicalTrials.gov/show/NCT01095185 Completed Hospital Clinic of Barcelona 2013-09-30
NCT01082419 Acoustic Radiation Force Impulse Imaging (ARFI) : a New Technique to Assess Liver Elasticity https://ClinicalTrials.gov/show/NCT01082419 Completed University Hospital, Bordeaux 2013-04-30
NCT01080144 Feasibility of Critical Flicker Frequency Procedure for the Diagnosis of Minimal Encephalopathy https://ClinicalTrials.gov/show/NCT01080144 Completed University Hospital, Toulouse 2012-10-31
NCT01072721 Non Invasive Study of the Hepatic Fibrosis in Paediatrics by the Method of Study of Pediatric Hepatic Fibrosis https://ClinicalTrials.gov/show/NCT01072721 Completed Assistance Publique - Hôpitaux de Paris 2017-07-11
NCT01062750 Liver Regeneration Therapy by Intrahepatic Arterial Administration of Autologous Adipose Tissue Derived Stromal Cells https://ClinicalTrials.gov/show/NCT01062750 Completed Kanazawa University 2015-02-28
NCT02022137 Fructans, Lactitol and Lactose in Minimal Hepatic Encephalopathy https://ClinicalTrials.gov/show/NCT02022137 Completed Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 2015-08-31
NCT01045525 Phlebotomy and Lifestyle and Diet Advices vs Lifestyle and Diet Advices Only in Patients With Dysmetabolic Liversiderosis https://ClinicalTrials.gov/show/NCT01045525 Completed Rennes University Hospital 2015-06-30
NCT01013194 Human Fetal Liver Cell Transplantation in Chronic Liver Failure https://ClinicalTrials.gov/show/NCT01013194 Completed The Mediterranean Institute for Transplantation and Advanced Specialized Therapies 2011-04-30
NCT01006031 Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4 https://ClinicalTrials.gov/show/NCT01006031 Completed Sociedad Andaluza de Enfermedades Infecciosas 2011-12-31
NCT00999167 A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy https://ClinicalTrials.gov/show/NCT00999167 Completed Horizon Pharma Ireland, Ltd., Dublin Ireland 2012-04-30
NCT00990639 Effect of Candesartan in Alcoholic Liver Fibrosis https://ClinicalTrials.gov/show/NCT00990639 Completed Yonsei University 2008-12-31
NCT00968695 Effects of Long Term Albumin 20% Administration in Patients With Cirrhosis and Ascites. https://ClinicalTrials.gov/show/NCT00968695 Completed Grifols Therapeutics LLC 2014-04-30
NCT00965900 Endoscopic Band Ligation (EBL) Versus Propranolol for Primary Prophylaxis of Variceal Bleeding https://ClinicalTrials.gov/show/NCT00965900 Recruiting Korea University 2019-05-31
NCT00965744 A Clinical Trial of the Vessel Sealing System (LigaSure) in Azygoportal Disconnection and Splenectomy in Patients With Portal Hypertension https://ClinicalTrials.gov/show/NCT00965744 Completed Shanghai Changzheng Hospital 2008-12-31
NCT00006164 Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment https://ClinicalTrials.gov/show/NCT00006164 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2007-04-30
NCT00956098 Efficacy and Safety of Oltipraz in the Patients With Liver Fibrosis and Cirrhosis https://ClinicalTrials.gov/show/NCT00956098 Completed CJ HealthCare Corporation NA
NCT00955500 Effects of Proteins in Patients With Cirrhosis and Prior Hepatic Encephalopathy https://ClinicalTrials.gov/show/NCT00955500 Completed Hospital Universitari Vall d’Hebron Research Institute 2008-01-31
NCT00943176 Modafinil in the Treatment of Fatigue in Patients With Primary Biliary Cirrhosis (PBC) https://ClinicalTrials.gov/show/NCT00943176 Completed Mayo Clinic 2011-04-30
NCT00921349 A Trial of Ligation Plus Nadolol Versus Nadolol Alone in the Prophylaxis of First Variceal Bleeding in Cirrhosis https://ClinicalTrials.gov/show/NCT00921349 Completed National Science Council, Taiwan 2009-05-31
NCT00896597 Reproducibility of Child-Turcotte-Pugh (CTP) Rating and NRL972 Pharmacokinetics in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT00896597 Completed Norgine 2009-12-31
NCT00896233 Magnetic Resonance Elastography for Assessment of Liver Fibrosis (MK-0000-132)(COMPLETED) https://ClinicalTrials.gov/show/NCT00896233 Completed Merck Sharp & Dohme Corp. 2010-01-31
NCT00886925 Efficacy of Albumin for Acute Encephalopathy in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT00886925 Completed Hospital Universitari Vall d’Hebron Research Institute 2012-07-31
NCT00885313 Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD) https://ClinicalTrials.gov/show/NCT00885313 Completed Bambino Gesù Hospital and Research Institute 2010-04-30
NCT00857480 Evaluation of the PK of NRL972 Following Pre- and co-Administration of Ursodeoxycholic Acid and Cloxacillin https://ClinicalTrials.gov/show/NCT00857480 Completed Norgine 2006-08-31
NCT00856869 Clearance of NRL972 in Patients With Cirrhosis, Nonalcoholic Steatohepatitis (NASH) and in Healthy Volunteers https://ClinicalTrials.gov/show/NCT00856869 Completed Norgine 2005-02-28
NCT00856713 Clearance of NRL972 in Patients With Cirrhosis and in Healthy Volunteers https://ClinicalTrials.gov/show/NCT00856713 Completed Norgine 2006-08-31
NCT00844402 Safety and Efficacy of Long-Term Treatment With Atorvastatin in Patients With Primary Biliary Cirrhosis https://ClinicalTrials.gov/show/NCT00844402 Completed Medical University of Graz 2007-11-30
NCT02021253 Influence of Probiotics Administration Before Liver Resection in Liver Disease https://ClinicalTrials.gov/show/NCT02021253 Completed University Hospital, Rouen 2018-04-12
NCT04178096 Using Data-Driven Implementation Strategies to Improve the Quality of Cirrhosis Care https://ClinicalTrials.gov/show/NCT04178096 Enrolling by invitation VA Office of Research and Development 2022-09-30
NCT04113317 Granulocyte-Colony Stimulating Factor (G-CSF) as Optimizing Therapy for Pediatric Liver Transplantation https://ClinicalTrials.gov/show/NCT04113317 Enrolling by invitation Fakultas Kedokteran Universitas Indonesia 2021-09-16
NCT00831337 Evaluation of Probiotics in the Treatment of Portal Hypertension https://ClinicalTrials.gov/show/NCT00831337 Completed Pomeranian Medical University Szczecin 2010-11-30
NCT04195724 Microbiome Translocation in Different Circulatory Compartments in Decompensated Cirrhosis https://ClinicalTrials.gov/show/NCT04195724 Recruiting Nanfang Hospital of Southern Medical University 2020-12-31
NCT02787772 Abdominal Hernia in Cirrhotic Patients: Surgery or Conservative Treatment? https://ClinicalTrials.gov/show/NCT02787772 Completed University of Sao Paulo General Hospital 2014-11-30
NCT02514434 Usefulness of Non-contrast MagnetIc Resonance imAging Versus Non-Contrast Ultrasonography for surveiLlancE of HepatoCellular Carcinoma [MIRACLE-HCC] https://ClinicalTrials.gov/show/NCT02514434 Active, not recruiting Yonsei University 2022-12-31
NCT01188733 Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT01188733 Completed Mayo Clinic 2000-07-31
NCT00816127 Prevention of Bleeding in Patient With Cirrhosis Undergoing Dental Extraction https://ClinicalTrials.gov/show/NCT00816127 Completed Icahn School of Medicine at Mount Sinai 2007-05-31
NCT01995071 A Study to Evaluate the Safety and Antiviral Effect of Multiple Doses of ABT-493 and ABT-530 in Adults With Genotype 1 Hepatitis C Virus (HCV) https://ClinicalTrials.gov/show/NCT01995071 Completed AbbVie 2015-06-30
NCT04330469 Periodontal Therapy and Oral-gut-hepatic Axis Cirrhosis: a Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT04330469 Recruiting Postgraduate Institute of Medical Education and Research 2021-03-30
NCT01349335 Dose Exploring and Setting Study for Tolvaptan to Treat Hepatic Cirrhosis With Ascites https://ClinicalTrials.gov/show/NCT01349335 Completed Otsuka Beijing Research Institute 2010-01-31
NCT00805805 Study Comparing Tetrathiomolybdate vs Standard Treatment in Primary Biliary Cirrhosis https://ClinicalTrials.gov/show/NCT00805805 Completed University of Michigan 2008-12-31
NCT03028740 AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH https://ClinicalTrials.gov/show/NCT03028740 Recruiting Tobira Therapeutics, Inc. 2021-10-14
NCT03770936 Effect of Some Drugs on Liver Fibrosis https://ClinicalTrials.gov/show/NCT03770936 Recruiting Tanta University 2026-10-31
NCT03731923 Abbreviated MRI for HCC Surveillance https://ClinicalTrials.gov/show/NCT03731923 Recruiting Seoul National University Hospital 2021-12-31
NCT03080129 Microbiome and Sarcopenia in Patients With Liver Cirrhosis https://ClinicalTrials.gov/show/NCT03080129 Recruiting Medical University of Graz 2021-07-31
NCT03209986 Trial of Mesenchymal Stem Cell Transplantation in Decompensated Liver Cirrhosis https://ClinicalTrials.gov/show/NCT03209986 Recruiting Xijing Hospital of Digestive Diseases 2019-06-30
NCT03091738 Ramelteon for Treatment of Insomnia in Cirrhosis https://ClinicalTrials.gov/show/NCT03091738 Completed Virginia Commonwealth University 2018-10-01
NCT02682108 Diffusion-weighted Imaging Magnetic Resonance for Assessing Liver Fibrosis https://ClinicalTrials.gov/show/NCT02682108 Completed Mahidol University 2016-06-30
NCT02642432 A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis https://ClinicalTrials.gov/show/NCT02642432 Completed AbbVie 2016-10-27
NCT02744105 Effect of Spirulina on Liver Fibrosis by Transient Elastography in Beta Thalassemic Children With Hepatitis C https://ClinicalTrials.gov/show/NCT02744105 Completed Tanta University 2017-12-31
NCT02298868 Safety and Efficacy of Baclofen for Treatment of Muscle Spasms in Patients With Cirrhosis: A Pilot Study https://ClinicalTrials.gov/show/NCT02298868 Completed University of Virginia 2013-11-30
NCT02207088 Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease https://ClinicalTrials.gov/show/NCT02207088 Completed AbbVie 2016-12-06
NCT02178319 Laparoscopic Versus Open Devascularization for Portal Hypertension, a Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT02178319 Recruiting Second Affiliated Hospital of Xi’an Jiaotong University 2021-06-30
NCT04357600 Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B https://ClinicalTrials.gov/show/NCT04357600 Recruiting PT. Prodia Stem Cell Indonesia 2020-12-20
NCT04210245 Study of Aldafermin (NGM282) in Subjects With Compensated Cirrhosis (ALPINE 4) https://ClinicalTrials.gov/show/NCT04210245 Recruiting NGM Biopharmaceuticals, Inc 2022-06-30
NCT04073693 Characterization of the Nutritional Status in the Patient With Liver Cirrhosis https://ClinicalTrials.gov/show/NCT04073693 Completed Puerta de Hierro University Hospital 2019-08-01
NCT00772057 Beta-blockers for Prevention Of Growth Of Small Esophageal Varices In Cirrhosis: An Randomized Controlled Trial (RCT) https://ClinicalTrials.gov/show/NCT00772057 Completed Govind Ballabh Pant Hospital 2008-10-31
NCT00764049 Single Pass Albumin Dialysis in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT00764049 Completed Assistance Publique - Hôpitaux de Paris 2012-01-31
NCT00741663 Spironolactone Versus Spironolactone Plus Furosemide (SVSSF) https://ClinicalTrials.gov/show/NCT00741663 Completed University of Padova 2008-09-30
NCT00736840 BreathID 13C-Methacetin Breath Test for Detecting Cirrhosis https://ClinicalTrials.gov/show/NCT00736840 Completed Exalenz Bioscience LTD. 2009-09-30
NCT00713934 Autologous Bone Marrow Stem Cells in Cirrhosis Patients https://ClinicalTrials.gov/show/NCT00713934 Completed Royan Institute 2009-01-31
NCT00701792 Liver Transplantation Versus Alternative Therapies for Patients With Pugh B Alcoholic Cirrhosis https://ClinicalTrials.gov/show/NCT00701792 Completed Centre Hospitalier Universitaire de Besancon 2006-11-30
NCT00698464 Pharmacokinetics and Safety of Single Subcutaneous Pasireotide (SOM230) in Subjects With Varying Degrees of Hepatic Function https://ClinicalTrials.gov/show/NCT00698464 Completed Novartis 2009-04-30
NCT00689754 Efficacy and Safety Study on Nasogastric (NG) Tube in Patients With Upper Gastrointestinal Bleed https://ClinicalTrials.gov/show/NCT00689754 Completed University of Texas Southwestern Medical Center 2011-08-31
NCT00687219 Efficacy and Safety of Peginterferon Alfa-2b and Ribavirin Therapy in Subjects With Type C Compensated Liver Cirrhosis (Study P05116) https://ClinicalTrials.gov/show/NCT00687219 Completed Merck Sharp & Dohme Corp. 2010-10-31
NCT02078882 Study of Abatacept (Orencia) to Treat Primary Biliary Cirrhosis https://ClinicalTrials.gov/show/NCT02078882 Completed University of California, Davis 2018-10-31
NCT00628160 Terlipressin in Septic Shock in Cirrhosis https://ClinicalTrials.gov/show/NCT00628160 Completed Hospital Clinic of Barcelona 2012-12-31
NCT00594191 Efficacy and Safety of Simvastatin in the Treatment of Portal Hypertension https://ClinicalTrials.gov/show/NCT00594191 Completed Hospital Clinic of Barcelona 2007-04-30
NCT00592475 A Study to Assess the Safety and Effects of Intravenous (IV) Conivaptan on the Hepatic Hemodynamic Response in Cirrhotic Patients https://ClinicalTrials.gov/show/NCT00592475 Completed Cumberland Pharmaceuticals 2008-11-30
NCT00588302 Moexipril for Primary Biliary Cirrhosis https://ClinicalTrials.gov/show/NCT00588302 Completed Mayo Clinic 2007-06-30
NCT00575042 Use of Fenofibrate for Primary Biliary Cirrhosis https://ClinicalTrials.gov/show/NCT00575042 Completed University of Florida 2009-08-31
NCT00570765 Study of INT-747 as Monotherapy in Patients With PBC https://ClinicalTrials.gov/show/NCT00570765 Completed Intercept Pharmaceuticals 2010-09-30
NCT00570622 Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosis https://ClinicalTrials.gov/show/NCT00570622 Completed Medical University of Vienna 2008-11-30
NCT00562783 A Phase II, Double-blinded, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Vitalliver in Patients With Decompensated Cirrhosis https://ClinicalTrials.gov/show/NCT00562783 Completed Hospital Authority, Hong Kong NA
NCT00820781 Endoscopic Sclerotherapy and/or Ligation Versus Portacaval Shunt for Bleeding Gastric Varices https://ClinicalTrials.gov/show/NCT00820781 Completed University of California, San Diego 1977-12-31
NCT00550862 Study of INT 747 in Combination With URSO in Patients With Primay Biliary Cirrhosis (PBC) https://ClinicalTrials.gov/show/NCT00550862 Completed Intercept Pharmaceuticals 2009-08-31
NCT00525252 Efficacy of Baclofen in the Treatment of Alcohol Addiction https://ClinicalTrials.gov/show/NCT00525252 Completed Catholic University of the Sacred Heart NA
NCT00502086 Efficacy and Safety of Viusid in Patients With Hepatic Cirrhosis Secondary to Hepatitis C Virus Infection. https://ClinicalTrials.gov/show/NCT00502086 Completed Catalysis SL 2009-07-31
NCT00501722 Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic Ascites https://ClinicalTrials.gov/show/NCT00501722 Completed Sanofi 2005-03-31
NCT00501566 Satavaptan Dose-Ranging Study in Normonatraemic Patients With Cirrhotic Ascites https://ClinicalTrials.gov/show/NCT00501566 Completed Sanofi NA
NCT00501384 Satavaptan Dose-Ranging Study in the Prevention of Ascites https://ClinicalTrials.gov/show/NCT00501384 Completed Sanofi 2005-05-31
NCT00490620 Study of Combivir for Patients With Primary Biliary Cirrhosis https://ClinicalTrials.gov/show/NCT00490620 Completed University of Alberta NA
NCT00469131 Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + Steroid https://ClinicalTrials.gov/show/NCT00469131 Completed Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 2010-08-31
NCT00420134 Improvement of Liver Function in Liver Cirrhosis Patients After Autologous Mesenchymal Stem Cell Injection:a Phase I-II Clinical Trial https://ClinicalTrials.gov/show/NCT00420134 Completed Shahid Beheshti University of Medical Sciences 2009-05-31
NCT00406237 Pharmacokinetic Study Of Tigecycline In Adult Subjects With Primary Biliary Cirrhosis https://ClinicalTrials.gov/show/NCT00406237 Completed Wyeth is now a wholly owned subsidiary of Pfizer 2009-03-31
NCT00378599 Effects of Pegylated Interferon Alfa-2b and Ribavirin After Orthotopic Liver Transplantation in Subjects With Chronic Hepatitis C Recurrence (P04590AM3)(COMPLETED) https://ClinicalTrials.gov/show/NCT00378599 Completed Merck Sharp & Dohme Corp. 2009-07-31
NCT00926224 Fibroscan® and Its Dedicated Probes Efficiency in Obese Patients https://ClinicalTrials.gov/show/NCT00926224 Completed Echosens 2010-07-31
NCT00364819 Initial Study of Rituximab to Treat Primary Biliary Cirrhosis https://ClinicalTrials.gov/show/NCT00364819 Completed University of California, Davis 2009-07-31
NCT00359853 Norfloxacin In The Primary Prophylaxis Of Spontaneous Bacterial Peritonitis https://ClinicalTrials.gov/show/NCT00359853 Completed Hospital Clinic of Barcelona NA
NCT00358878 Cirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS) https://ClinicalTrials.gov/show/NCT00358878 Completed Sanofi 2008-12-31
NCT00347009 Adefovir Dipivoxil For The Treatment Of Patients With Chronic Hepatitis B Related Advanced Fibrosis Or Cirrhosis https://ClinicalTrials.gov/show/NCT00347009 Completed GlaxoSmithKline 2009-09-30
NCT00344916 Phase 1 Study of L-NMMA in Patients With Liver Cirrhosis https://ClinicalTrials.gov/show/NCT00344916 Completed Regional Hospital Holstebro NA
NCT00323804 Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy. https://ClinicalTrials.gov/show/NCT00323804 Completed French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) 2013-02-28
NCT00312910 Probiotics for the Prevention of Major Complications of Cirrhosis https://ClinicalTrials.gov/show/NCT00312910 Completed Meir Medical Center NA
NCT00304551 A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC) https://ClinicalTrials.gov/show/NCT00304551 Completed Chugai Pharmaceutical 2009-12-31
NCT00301509 Antiviral Therapy in Decompensated Hepatitis C Virus (HCV) Cirrhosis https://ClinicalTrials.gov/show/NCT00301509 Completed Casa Sollievo della Sofferenza IRCCS NA
NCT00298714 Effects of Losartan on Hepatic Fibrogenesis in Chronic Hepatitis C https://ClinicalTrials.gov/show/NCT00298714 Completed Hospital Clinic of Barcelona NA
NCT00296244 Steroid Free Immunosuppression in Liver Transplantation https://ClinicalTrials.gov/show/NCT00296244 Completed Thomas Jefferson University 2008-05-31
NCT00287235 Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS) https://ClinicalTrials.gov/show/NCT00287235 Completed Baxter Healthcare Corporation 2003-11-30
NCT00275652 A Comparison of the Drug Telbivudine (LdT) and Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis. https://ClinicalTrials.gov/show/NCT00275652 Completed Mayo Clinic 2007-08-31
NCT03468699 Autologous Bone Marrow Mononuclear Stem Cell for Children Suffering From Liver Cirrhosis Due to Biliary Atresia https://ClinicalTrials.gov/show/NCT03468699 Recruiting Vinmec Research Institute of Stem Cell and Gene Technology 2019-12-31
NCT00273247 Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis https://ClinicalTrials.gov/show/NCT00273247 Completed National Cancer Institute, Milan NA
NCT00252642 Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis C https://ClinicalTrials.gov/show/NCT00252642 Completed Virginia Commonwealth University 2007-09-30
NCT00245830 Ischemic Preconditioning of Liver in Cadaver Donors https://ClinicalTrials.gov/show/NCT00245830 Completed Rutgers, The State University of New Jersey 2006-07-31
NCT00244751 Antifibrotic Activity Of GI262570 In Chronic Hepatitis C Subjects https://ClinicalTrials.gov/show/NCT00244751 Completed GlaxoSmithKline 2008-03-13
NCT00244569 Development of a Breath Test for Monitoring Patients With Liver Disease https://ClinicalTrials.gov/show/NCT00244569 Completed Virginia Commonwealth University 2007-04-30
NCT00243633 Characterization of Focal Liver Lesions by Real-Time Contrast-Enhanced Ultrasound Imaging (CEUS) https://ClinicalTrials.gov/show/NCT00243633 Completed University Hospital, Tours 2006-12-31
NCT00232427 PiCCO Guided Therapy in Liver Cirrhosis https://ClinicalTrials.gov/show/NCT00232427 Completed Heidelberg University NA
NCT00222014 TIPS With Coated Stents for Refractory Ascites in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT00222014 Completed University Hospital, Toulouse 2012-12-31
NCT00212186 Selenium Supplementation of Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT00212186 Completed Vanderbilt University 2003-11-30
NCT00190385 Screening of Hepatocellular Carcinoma in Patients With Compensated Cirrhosis https://ClinicalTrials.gov/show/NCT00190385 Completed Assistance Publique - Hôpitaux de Paris 2009-07-31
NCT00179413 Study of Long-term Peg Intron vs. Colchicine in Non-responders. https://ClinicalTrials.gov/show/NCT00179413 Completed Beth Israel Deaconess Medical Center 2009-12-31
NCT00180674 Anticoagulation in Liver Fibrosis in Patients With Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT00180674 Completed Imperial College London 2006-09-30
NCT00168961 Enteral Nutrition in Liver Cirrhosis https://ClinicalTrials.gov/show/NCT00168961 Completed Charite University, Berlin, Germany 2006-12-31
NCT00162552 Clinical Trial of Pentoxifylline in Patient With Cirrhosis https://ClinicalTrials.gov/show/NCT00162552 Completed Assistance Publique - Hôpitaux de Paris 2007-12-31
NCT00154492 Use of NovoSeven® in Active Variceal Bleeding https://ClinicalTrials.gov/show/NCT00154492 Completed Novo Nordisk A/S 2006-08-31
NCT00147043 Adult Stem Cell Therapy in Liver Insufficiency https://ClinicalTrials.gov/show/NCT00147043 Completed Imperial College London 2005-06-30
NCT00124228 Albumin Administration in Patients With Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis https://ClinicalTrials.gov/show/NCT00124228 Completed Hospital Clinic of Barcelona 2008-10-31
NCT00122616 Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and Hepatitis C https://ClinicalTrials.gov/show/NCT00122616 Completed French National Agency for Research on AIDS and Viral Hepatitis 2009-03-31
NCT00115947 Renal and Cardiovascular Effects of Terlipressin in Patients With Cirrhosis and Ascites https://ClinicalTrials.gov/show/NCT00115947 Completed Hvidovre University Hospital NA
NCT00108355 Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis https://ClinicalTrials.gov/show/NCT00108355 Completed VA Office of Research and Development 2010-08-31
NCT00076336 Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis https://ClinicalTrials.gov/show/NCT00076336 Completed Novartis 2009-12-31
NCT00058903 Treatment of Cholestatic Pruritus With Sertraline https://ClinicalTrials.gov/show/NCT00058903 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NA
NCT00049842 Prevention of Disease Progress in Chronic Hepatitis C Patients With Liver Fibrosis (Study P02570AM2)(COMPLETED) https://ClinicalTrials.gov/show/NCT00049842 Completed Merck Sharp & Dohme Corp. 2009-10-31
NCT00048724 Peg-Intron for Prevention of Disease Progress in Chronic Hepatitis C Patients With Cirrhosis (Study P02569) https://ClinicalTrials.gov/show/NCT00048724 Completed Merck Sharp & Dohme Corp. 2008-04-30
NCT00043303 Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or Cirrhosis https://ClinicalTrials.gov/show/NCT00043303 Completed InterMune NA
NCT00039871 PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370) https://ClinicalTrials.gov/show/NCT00039871 Completed Merck Sharp & Dohme Corp. 2007-09-30
NCT00794911 Quality of Life Therapy for Adults With Hepatitis C Virus and Cirrhosis Awaiting Liver Transplantation https://ClinicalTrials.gov/show/NCT00794911 Completed Beth Israel Deaconess Medical Center 2010-12-31
NCT00794482 Multi-national Cirrhosis Study to Characterise the Association Between the Pharmacokinetics of NRL972 and Disease Severity. https://ClinicalTrials.gov/show/NCT00794482 Completed Norgine 2009-06-30
NCT00006161 Decompression Intervention of Variceal Rebleeding Trial (DIVERT) https://ClinicalTrials.gov/show/NCT00006161 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NA
NCT00543426 Fuzheng Huayu Tablets Against Posthepatitic Cirrhosis https://ClinicalTrials.gov/show/NCT00543426 Completed Shanghai University of Traditional Chinese Medicine 2009-05-31
NCT00517738 Effect of Physical Training Program on Health-related Quality of Life in Cirrhosis https://ClinicalTrials.gov/show/NCT00517738 Completed Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 2014-01-31
NCT00006398 Prevention of Esophageal Varices by Beta-Adrenergic Blockers https://ClinicalTrials.gov/show/NCT00006398 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2002-09-30
NCT00004842 Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis https://ClinicalTrials.gov/show/NCT00004842 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 1999-04-30
NCT00004796 Phase II Study of Lactulose and Circadian Rhythms in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT00004796 Completed Office of Rare Diseases (ORD) NA
NCT00004784 Phase III Randomized Study of Ursodiol With Vs Without Methotrexate for Primary Biliary Cirrhosis https://ClinicalTrials.gov/show/NCT00004784 Completed Office of Rare Diseases (ORD) NA
NCT00004748 Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis https://ClinicalTrials.gov/show/NCT00004748 Completed Office of Rare Diseases (ORD) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03405909 Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter Study https://ClinicalTrials.gov/show/NCT03405909 Recruiting University Hospital Erlangen 2020-02-29
NCT03389152 SWE Liver Stiffness as a Predictor of Progression of Chronic Liver Diseases https://ClinicalTrials.gov/show/NCT03389152 Enrolling by invitation SuperSonic Imagine 2018-11-28
NCT03382119 Increased Liver Stiffness: A Study of Acoustic Radiation Force Impulse (ARFI) Elastography https://ClinicalTrials.gov/show/NCT03382119 Completed University of Michigan 2019-07-19
NCT04131205 Role of MRI in Detection of Minimal Hepatic Encephalopathy https://ClinicalTrials.gov/show/NCT04131205 Recruiting University Medical Centre Ljubljana 2023-06-01
NCT03342703 Correlation of Ultrasound Based Measurements of Liver Stiffness and Steatosis With MRI https://ClinicalTrials.gov/show/NCT03342703 Recruiting Stanford University 2020-08-01
NCT03277651 Noninvasive Diagnostic Platform for Liver Fibrosis and Portal Hypertension https://ClinicalTrials.gov/show/NCT03277651 Recruiting Shanghai Zhongshan Hospital 2019-12-31
NCT03242798 Assessment of Nutritional Status of Patients With Liver Cirrhosis https://ClinicalTrials.gov/show/NCT03242798 Active, not recruiting Harokopio University 2018-10-31
NCT03228095 Volatiles in Breath and Headspace Analysis - Diagnostic Markers https://ClinicalTrials.gov/show/NCT03228095 Enrolling by invitation University of Latvia 2019-12-20
NCT03198104 Assessing Kids for Liver Inflammation and Fibrosis Using Non-invasive MRI https://ClinicalTrials.gov/show/NCT03198104 Completed Perspectum Diagnostics Ltd 2019-03-01
NCT03158818 Chronic Hepatitis B Virus Infection in Zambia https://ClinicalTrials.gov/show/NCT03158818 Recruiting University of Alabama at Birmingham 2021-01-31
NCT03156426 Prognostic Biomarkers For Acute Kidney Injury In Liver Cirrhosis https://ClinicalTrials.gov/show/NCT03156426 Completed University of Edinburgh 2017-11-15
NCT03149627 Chronic Hepatitis B Virus Clinical Epidemiology in a Representative Sample of Zambian Adults https://ClinicalTrials.gov/show/NCT03149627 Completed University of Alabama at Birmingham 2018-12-19
NCT03144700 The Natural History and Prognostic Factors of Compensated Cirrhosis. https://ClinicalTrials.gov/show/NCT03144700 Recruiting Institute of Liver and Biliary Sciences, India 2021-01-31
NCT03137719 Infections in Hospitalized Cirrhotic Patients https://ClinicalTrials.gov/show/NCT03137719 Active, not recruiting Baylor Research Institute 2020-05-30
NCT03121404 Mechanisms of Malnutrition in Cirrhosis With Portosystemic Shunting https://ClinicalTrials.gov/show/NCT03121404 Recruiting The Cleveland Clinic 2025-12-31
NCT03114813 Can MRI Evaluate Beta-blocker Response in Portal Hypertension? https://ClinicalTrials.gov/show/NCT03114813 Recruiting University of Nottingham 2019-07-31
NCT03083925 Viatorr CX Case-control Study for Complications of Portal Hypertension https://ClinicalTrials.gov/show/NCT03083925 Completed University Hospital, Bonn 2018-12-01
NCT03072615 Role of SWE-change After TIPS in the Prediction of Prognosis After TIPS https://ClinicalTrials.gov/show/NCT03072615 Completed University Hospital, Bonn 2015-11-30
NCT03056612 Predicting Acute-on-Chronic Liver Failure in Cirrhosis (PREDICT) Study https://ClinicalTrials.gov/show/NCT03056612 Completed European Foundation for Study of Chronic Liver Failure 2018-07-31
NCT03053180 Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir (r) - Ombitasvir, + Dasabuvir Without Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis in the Russian Federation https://ClinicalTrials.gov/show/NCT03053180 Completed AbbVie 2017-12-18
NCT03042520 Long-term Outcomes of Chronic Hepatitis C Patients Post Sofosbuvir-based Treatment https://ClinicalTrials.gov/show/NCT03042520 Recruiting Kaohsiung Medical University Chung-Ho Memorial Hospital 2022-09-30
NCT02996188 Acute Hemodynamic Changes During Paracentesis https://ClinicalTrials.gov/show/NCT02996188 Completed Universitätsmedizin Mannheim 2013-11-30
NCT02926261 Methods for Nutritional Assessment in Cirrhosis https://ClinicalTrials.gov/show/NCT02926261 Recruiting Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 2020-12-31
NCT02806011 Long-term Follow-up Study of Livercellgram in Alcoholic LC Patients Who Completed Livercellgram Phase 2 Study https://ClinicalTrials.gov/show/NCT02806011 Enrolling by invitation Pharmicell Co., Ltd. 2021-12-31
NCT02785835 Hepatocellular Carcinoma in HIV-infected Patients https://ClinicalTrials.gov/show/NCT02785835 Recruiting Hospital Universitario de Valme 2016-12-31
NCT02593799 Non-invasive Prediction of Esophageal Varices in Liver Cirrhosis: A Multicenter Observational Study https://ClinicalTrials.gov/show/NCT02593799 Completed General Hospital of Shenyang Military Region 2018-12-31
NCT00001971 Evaluation of Patients With Liver Disease https://ClinicalTrials.gov/show/NCT00001971 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT02542020 Prospective Evaluation of HIV Patients Using Non-invasive Methods for Estimation of Liver Fibrosis and Steatosis https://ClinicalTrials.gov/show/NCT02542020 Recruiting Oswaldo Cruz Foundation 2020-05-31
NCT02534805 Patient Buddy App for the Prevention of Avoidable Readmission in Cirrhosis https://ClinicalTrials.gov/show/NCT02534805 Completed Virginia Commonwealth University 2017-01-31
NCT02484534 Thrombin Generation Test in Patient With Liver Cirrhosis https://ClinicalTrials.gov/show/NCT02484534 Completed HaEmek Medical Center, Israel 2015-12-09
NCT02421848 Lean Mass Evaluation of Cirrhotic Patients With Ascites With the Use DXA https://ClinicalTrials.gov/show/NCT02421848 Completed University of Sao Paulo 2012-05-31
NCT02400216 Deciphering the Mechanisms Involved in Microbial Translocation Across the Spectrum of HCV Associated Liver Fibrosis https://ClinicalTrials.gov/show/NCT02400216 Completed National Institutes of Health Clinical Center (CC) 2017-02-24
NCT02389127 Relationship Between HbA1c and Chronic Glycemia in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT02389127 Completed University of Arkansas 2017-06-01
NCT02372682 Shear Wave Sonoelastography in Pediatric Liver Fibrosis https://ClinicalTrials.gov/show/NCT02372682 Completed St. Louis University 2018-05-31
NCT02353767 Evaluation of Liver Fibrosis in HIV-infected Patients With Metabolic Syndrome https://ClinicalTrials.gov/show/NCT02353767 Completed Institut de Médecine et d’Epidémiologie Appliquée - Fondation Internationale Léon M’Ba 2013-02-28
NCT02348814 Development of a Novel Biomarker for Liver Fibrosis https://ClinicalTrials.gov/show/NCT02348814 Completed University of California, Los Angeles 2019-01-26
NCT02344680 Liver Fibrosis in Zambian HIV-HBV Co-infected Patients https://ClinicalTrials.gov/show/NCT02344680 Active, not recruiting University of Alabama at Birmingham 2024-08-31
NCT02335580 Effect of Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis https://ClinicalTrials.gov/show/NCT02335580 Recruiting General Hospital of Shenyang Military Region 2020-12-31
NCT02335073 Effect of 4 Liver Fibrosis Tests (PIIINP, CIV, LN, and HA) on the Prognosis of Liver Cirrhosis https://ClinicalTrials.gov/show/NCT02335073 Completed General Hospital of Shenyang Military Region 2016-06-30
NCT02313649 ShearWaveâ„¢ Elastography to Assess Liver Fibrosis in Chinese Patients With Hepatitis B https://ClinicalTrials.gov/show/NCT02313649 Completed SuperSonic Imagine 2016-04-30
NCT02181452 Liver Fibrosis Assessment With ShearWave Elastography https://ClinicalTrials.gov/show/NCT02181452 Completed SuperSonic Imagine 2014-06-30
NCT02174367 An Observational Cohort Study Evaluating Fatty Liver Disease and Liver Fibrosis in Moderate to Severe Psoriasis https://ClinicalTrials.gov/show/NCT02174367 Active, not recruiting King’s College London 2017-07-31
NCT02163512 Effect of Beta-adrenergic Blockers on Cardiac Function, Systemic and Splanchnic Haemodynamic and Kidney Function in Cirrhotic Patiets With Refractory Ascites https://ClinicalTrials.gov/show/NCT02163512 Completed Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 2018-05-31
NCT02132351 Hepatic Fibrosis Non-invasive Methods Questionnaire https://ClinicalTrials.gov/show/NCT02132351 Completed Al-Azhar University 2016-04-30
NCT02125071 Study on the Pharmacokinetic Characteristics of I.V. Hepabig Injection Used for Prevention of Hepatitis B Relapse After Liver Transplantation https://ClinicalTrials.gov/show/NCT02125071 Completed Seoul St. Mary’s Hospital 2015-08-31
NCT02073435 A2ALL-Patients Safety System Improvements in Living Donor Liver Transplantation https://ClinicalTrials.gov/show/NCT02073435 Completed Northwestern University 2015-05-31
NCT02069457 Prevalence and Predictive Factors of Portal Vein Thrombosis in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT02069457 Completed Beijing Friendship Hospital 2014-06-30
NCT02060162 Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa https://ClinicalTrials.gov/show/NCT02060162 Active, not recruiting University of Alabama at Birmingham 2021-06-30
NCT01306110 Screening for Liver Fibrosis by Using Non-invasive Methods in Patients With Diabetes. A Prospective Study https://ClinicalTrials.gov/show/NCT01306110 Completed Association HGE CHU Bordeaux Sud 2010-12-31
NCT01283230 Evaluation of Liver Fibrosis Staging With Acoustic Radiation Force Impulse Elastography https://ClinicalTrials.gov/show/NCT01283230 Completed Yonsei University 2011-04-30
NCT02023190 Changes in Body Composition and Nutritional Status in Patients Undergoing Liver Transplantation https://ClinicalTrials.gov/show/NCT02023190 Recruiting Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 2020-12-31
NCT02023177 Phase Angle and Mortality in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT02023177 Completed Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 2013-07-31
NCT02047240 Renal Function Determination in Patients With Liver Cirrhosis https://ClinicalTrials.gov/show/NCT02047240 Completed Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 2015-12-31
NCT02044523 Noninvasive Staging of Liver Fibrosis: MR vs Ultrasound https://ClinicalTrials.gov/show/NCT02044523 Completed Centre hospitalier de l’Université de Montréal (CHUM) 2018-06-30
NCT02007746 Liver Fibrosis in Sickle Cell Disease https://ClinicalTrials.gov/show/NCT02007746 Active, not recruiting University of Miami 2018-12-31
NCT01988753 Non-invasive Biomarkers of Fibrosis in Pediatric Liver Diseases https://ClinicalTrials.gov/show/NCT01988753 Completed Baylor College of Medicine 2016-06-30
NCT01957618 The Follow-up Study of Chronic Hepatitis B Patients With Liver Cirrhosis Receiving Anti-HBV Therapy https://ClinicalTrials.gov/show/NCT01957618 Enrolling by invitation National Taiwan University Hospital 2012-01-31
NCT01944878 The Association With Peptic Ulcer Disease and Hepatic Vein Pressure Gradient https://ClinicalTrials.gov/show/NCT01944878 Completed Chuncheon Sacred Heart Hospital 2013-08-31
NCT01872793 Validation of BIVA for Nutritional Assessment in Cirrhotic Patients https://ClinicalTrials.gov/show/NCT01872793 Completed Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 2016-07-31
NCT01872767 Spectrum, Profile and Outcome of Infections in Patients With Cirrhosis and/ or Acute on Chronic Liver Failure https://ClinicalTrials.gov/show/NCT01872767 Completed Institute of Liver and Biliary Sciences, India 2014-11-30
NCT01850940 Efficacy and Safety of Tolvaptan in Cirrhotic Patients With Hyponatremia https://ClinicalTrials.gov/show/NCT01850940 Completed Beijing Friendship Hospital 2014-09-30
NCT01825213 Stratification of Patients With Chronic Liver Disease Using Multi Spectral CT https://ClinicalTrials.gov/show/NCT01825213 Completed Massachusetts General Hospital 2016-10-31
NCT01810458 Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (Liver AATD) https://ClinicalTrials.gov/show/NCT01810458 Completed University of Florida 2019-09-30
NCT01757730 Magnetic Resonance Elastography as a Method to Estimate Stiffness of Soft Tissues https://ClinicalTrials.gov/show/NCT01757730 Recruiting Ohio State University 2022-12-31
NCT01751191 HVPG for Rebleeding Risk Stratification https://ClinicalTrials.gov/show/NCT01751191 Completed Hospital Clinic of Barcelona 2012-11-30
NCT01750216 An Observational Study of Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) on Predictive Values of RVR on Sustained Virological Response in Different Stages of Liver Fibrosis in Treatment-Naïve Patients With Chronic Hepatitis C Genotype 1 https://ClinicalTrials.gov/show/NCT01750216 Completed Hoffmann-La Roche 2015-01-31
NCT01729611 Endothelial Function in Patients With Scleroderma or Cirrhosis With and Without Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT01729611 Recruiting The Cleveland Clinic 2021-03-31
NCT01701687 Biomarkers for the Prognosis of Decompensated Alcoholic Liver Disease https://ClinicalTrials.gov/show/NCT01701687 Completed University of Nottingham 2015-07-31
NCT01671046 An Observational Study To Assess Liver Fibrosis Stages in Patients With Chronic Hepatitis C Infection https://ClinicalTrials.gov/show/NCT01671046 Completed Hoffmann-La Roche 2015-12-31
NCT01629095 Genetic Studies of Non-Alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT01629095 Completed National Institutes of Health Clinical Center (CC) NA
NCT01619475 Adult-to-Adult Living Donor Transplant Cohort Study https://ClinicalTrials.gov/show/NCT01619475 Completed Arbor Research Collaborative for Health 2014-08-31
NCT01609049 An Observational Study of Peginterferon Alfa-2a in Combination With Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis https://ClinicalTrials.gov/show/NCT01609049 Completed Hoffmann-La Roche 2015-06-22
NCT01603953 Bioelectrical Impedance Vector Analysis in Cirrhotic Patients https://ClinicalTrials.gov/show/NCT01603953 Completed Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 2013-12-31
NCT01573325 HRQoL in the Low MELD Pre-tx Population https://ClinicalTrials.gov/show/NCT01573325 Completed Northwestern University 2012-07-31
NCT01494220 Validation of the Bispectral Index Monitor During Living Donor Liver Transplantation https://ClinicalTrials.gov/show/NCT01494220 Completed Mansoura University 2010-03-31
NCT01494064 Monitoring of Encephalopathy in Cirrhotic Patients Admitted in Intensive Care https://ClinicalTrials.gov/show/NCT01494064 Completed Assistance Publique - Hôpitaux de Paris 2014-10-31
NCT02024347 A New Screening Strategy for Varices https://ClinicalTrials.gov/show/NCT02024347 Completed Chinese University of Hong Kong 2016-06-30
NCT01492283 Pathophysiological Implications of the Incretin Hormones in Patients With Liver Disease With and Without Diabetes https://ClinicalTrials.gov/show/NCT01492283 Completed University Hospital, Gentofte, Copenhagen 2013-05-31
NCT01470547 Portal Vein Thrombosis Relevance on Liver Cirrhosis: Italian Venous Thrombotic Events Registry https://ClinicalTrials.gov/show/NCT01470547 Completed University of Roma La Sapienza 2017-04-30
NCT01446666 Gadoxetic Acid-MRI Versus Ultrasonography for the Surveillance of Hepatocellular Carcinoma in High-risk Patients https://ClinicalTrials.gov/show/NCT01446666 Completed Asan Medical Center 2014-12-31
NCT01369979 Hepatic Sugar Metabolism Measured by PET/CT in Patients and Healthy Subjects https://ClinicalTrials.gov/show/NCT01369979 Completed University of Aarhus 2012-06-30
NCT01361061 AFP - L3% and DCP as Screening Marker for a Hepatocellular Carcinoma in Patients With Cirrhosis of the Liver https://ClinicalTrials.gov/show/NCT01361061 Completed University Hospital Freiburg 2015-11-30
NCT01355107 Comparison of Selenium Levels in HCV- Infected Patients at Different Stages of Disease https://ClinicalTrials.gov/show/NCT01355107 Completed University Hospital Freiburg 2011-12-31
NCT04389593 Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology as Reference https://ClinicalTrials.gov/show/NCT04389593 Recruiting University of California, San Diego 2020-12-31
NCT04380493 The Use of the Transient Elastography Paediatric Probe, Compared to the M Probe, Indirect Biomarkers and Histology https://ClinicalTrials.gov/show/NCT04380493 Completed Hospital Vall d’Hebron 2019-12-31
NCT04352309 Efficacy Study Of Oral Glecaprevir/Pibrentasvir Tablet In Pediatric (12 Years and Older) And Adult Treatment-Naive Participants With Chronic Hepatitis C Genotypes 1 To 6 And Liver Cirrhosis https://ClinicalTrials.gov/show/NCT04352309 Recruiting AbbVie 2021-04-20
NCT04345640 The Spectrum and Profile of COVID-19 Infection and Its Impact on Liver. https://ClinicalTrials.gov/show/NCT04345640 Recruiting Institute of Liver and Biliary Sciences, India 2020-06-30
NCT04332484 Global Coagulation Assessment in Cirrhosis and ACLF https://ClinicalTrials.gov/show/NCT04332484 Completed Postgraduate Institute of Medical Education and Research 2019-08-31
NCT04273750 RAI & HRS: Relationship Between Relative Adrenal Insufficiency and Failure of Treatment in Hepatorenal Syndrome https://ClinicalTrials.gov/show/NCT04273750 Completed University Hospital Plymouth NHS Trust 2020-02-05
NCT04267406 ADAMTS-13 and Von Willebrand Factor Levels and Activities in Children With Cirrhosis and/or Portal Hypertension https://ClinicalTrials.gov/show/NCT04267406 Completed Ataturk University 2019-10-30
NCT04265508 Assessment of Hemostatic Profile in Liver Cirrhosis https://ClinicalTrials.gov/show/NCT04265508 Completed Goethe University 2018-05-01
NCT04235166 Risk Assessment After Acute Upper Gastrointestinal Haemorrhage in Cirrhosis https://ClinicalTrials.gov/show/NCT04235166 Recruiting Affiliated Hospital to Academy of Military Medical Sciences 2020-05-31
NCT04221347 Novel Molecular Spectrometric Biomarkers in Blood Plasma as an Early Diagnostic Tool in HCC https://ClinicalTrials.gov/show/NCT04221347 Recruiting Military University Hospital, Prague 2020-12-31
NCT04199910 4beta-hydroxycholesterol in Cirrhosis https://ClinicalTrials.gov/show/NCT04199910 Recruiting University of Oulu 2021-12-31
NCT04179773 Chemotherapy and Liver Cirrhosis in Frequently-associated Cancers https://ClinicalTrials.gov/show/NCT04179773 Recruiting University Hospital, Lille 2025-01-31
NCT04173520 ELRIAH Score: A Simple Score for HCC Risk Stratification in CHC Patients With Cirrhosis or Advanced Liver Fibrosis Who Achieved SVR Following DAA Therapy https://ClinicalTrials.gov/show/NCT04173520 Completed Egyptian Liver Hospital 2019-08-31
NCT04168619 MTX-related Liver Toxicity in Psoriasis Patients, Using Ultrasound-based Techniques as a Diagnostic Tool https://ClinicalTrials.gov/show/NCT04168619 Recruiting The University of Hong Kong 2020-12-31
NCT04160897 Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated Cirrhosis https://ClinicalTrials.gov/show/NCT04160897 Enrolling by invitation Ruijin Hospital 2020-10-31
NCT04155398 EUS Elastography for Predicting Cirrhotic-related Complications https://ClinicalTrials.gov/show/NCT04155398 Recruiting Chinese University of Hong Kong 2022-12-31
NCT04125875 Gastric Slow Wave and Autonomic Nervous Function in Cirrhotic Patients With Esophageal Varices After Ligation-A Clinical Research https://ClinicalTrials.gov/show/NCT04125875 Completed The First Affiliated Hospital with Nanjing Medical University 2019-07-24
NCT04121520 Perioperative Care of HVPG Measurement (CHESS1904): An International Multicenter Survey https://ClinicalTrials.gov/show/NCT04121520 Recruiting Hepatopancreatobiliary Surgery Institute of Gansu Province 2020-10-31
NCT04116242 MERTK Signalling in Monocytes/Macrophages in Patients With Liver Disease https://ClinicalTrials.gov/show/NCT04116242 Recruiting University Hospital, Basel, Switzerland 2020-08-31
NCT04111120 Heparin Like Effect in Acute Variceal Bleeding https://ClinicalTrials.gov/show/NCT04111120 Recruiting Postgraduate Institute of Medical Education and Research 2020-12-31
NCT04076631 Surgical Stages of Liver Cirrhosis In Patients With Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT04076631 Recruiting Tongji Hospital 2020-09-30
NCT04076605 Bleeding in Hospitalized Patients With Liver Disease Undergoing Invasive Procedures https://ClinicalTrials.gov/show/NCT04076605 Recruiting University of Virginia 2020-11-01
NCT04058327 A Study of MHE in Patients With Liver Diseases https://ClinicalTrials.gov/show/NCT04058327 Recruiting Tongji Hospital 2020-06-30
NCT04057287 Risk Factors of Liver Fibrosis Among First Degree Relatives of Patients With NASH Related Cirrhosis (NRC) https://ClinicalTrials.gov/show/NCT04057287 Recruiting Institute of Liver and Biliary Sciences, India 2021-06-30
NCT04044248 TIPS Plus Transvenous Obliteration for Gastric Varices https://ClinicalTrials.gov/show/NCT04044248 Recruiting University of Illinois at Chicago 2021-04-04
NCT04036357 Liver Damage and Cardiometabolic Disorders in NAFLD https://ClinicalTrials.gov/show/NCT04036357 Recruiting University of Roma La Sapienza 2036-12-31
NCT03995537 Monocytic Expression of HLA-DR After Liver Transplantation https://ClinicalTrials.gov/show/NCT03995537 Recruiting Hospices Civils de Lyon 2021-09-26
NCT03990753 Microbiome/Peptidome-based Model for Non-invasive Detection of High-risk Gastroesophageal Varices in Compensated Cirrhosis (CHESS1901/APPHA1901) https://ClinicalTrials.gov/show/NCT03990753 Recruiting Nanfang Hospital of Southern Medical University 2020-06-12
NCT03979417 Identification of Biomarkers Related to Liver Fibrosis as New Therapeutic Targets https://ClinicalTrials.gov/show/NCT03979417 Recruiting Institut Pasteur 2022-09-01
NCT03943784 Endoscopic Variceal Ligation in Children https://ClinicalTrials.gov/show/NCT03943784 Completed Hospital Vall d’Hebron 2019-04-30
NCT03933891 Magnetic Resonance Technics for the Assessment of Liver Function Before and After TIPS https://ClinicalTrials.gov/show/NCT03933891 Recruiting West China Hospital 2024-08-30
NCT03919032 Bacterial Infections in Patients With Cirrhosis in Argentina: Clinical and Microbiological Characteristics https://ClinicalTrials.gov/show/NCT03919032 Completed Hospital Italiano de Buenos Aires 2019-12-31
NCT03896607 Liver and the Spleen Stifness in Adult Patients With Gaucher’s Disease Using Ultrasound Shear Wave Elastography https://ClinicalTrials.gov/show/NCT03896607 Recruiting HaEmek Medical Center, Israel 2021-02-01
NCT03884062 Clinical Impacts of Achieving SVR in Patients With Advanced Hepatic Fibrosis Related to Chronic HCV Treated With Direct Acting Antivirals https://ClinicalTrials.gov/show/NCT03884062 Completed Egyptian Liver Hospital 2018-06-01
NCT03878563 Alterations in Intestinal Mucosal Barrier Visualized by Confocal Laser Endomicroscopy in Liver Cirrhosis: a Pilot Trial (AMBIC) https://ClinicalTrials.gov/show/NCT03878563 Recruiting Spital Limmattal Schlieren 2020-11-20
NCT03878550 Case-Control Study of the Glycotestâ„¢ HCC Panel vs AFP for the Detection of Early-stage Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT03878550 Recruiting Glycotest, Inc. 2020-12-31
NCT03850977 Is There an Association Between Chronic Pancreatitis and Pulmonary Function https://ClinicalTrials.gov/show/NCT03850977 Recruiting Copenhagen University Hospital, Hvidovre 2025-12-31
NCT03846180 Terlipressin on Effect of Renal Function in Cirrhotic Patients With Acute Gastrointestinal Hemorrhage https://ClinicalTrials.gov/show/NCT03846180 Completed General Hospital of Shenyang Military Region 2019-06-30
NCT03837444 Microvesicles and Monocytes to Predict Mortality of Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT03837444 Recruiting Assistance Publique - Hôpitaux de Paris 2021-04-15
NCT03834285 Liver Disease in Pregnancy https://ClinicalTrials.gov/show/NCT03834285 Recruiting King’s College Hospital NHS Trust 2024-04-08
NCT03804593 HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC) https://ClinicalTrials.gov/show/NCT03804593 Completed Epigenomics, Inc 2019-10-01
NCT03789825 Population-based Study in Screening for Liver Fibrosis https://ClinicalTrials.gov/show/NCT03789825 Enrolling by invitation Fundacion Clinic per a la Recerca Biomédica 2020-12-31
NCT03778775 Transient Elastography (FibroTouch) for Assessing Risk of Gastroesophageal Varices Bleeding in Compensated Cirrhosis (Pan-CHESS1801) https://ClinicalTrials.gov/show/NCT03778775 Recruiting Nanfang Hospital of Southern Medical University 2019-10-13
NCT03753438 Intragastric Balloon in Compensated NASH(Non Alcoholic Steato Hepatitis) Cirrhotics https://ClinicalTrials.gov/show/NCT03753438 Recruiting Institute of Liver and Biliary Sciences, India 2020-06-30
NCT03749954 Magnetically Controlled Capsule Endoscopy for Assessing Risk of Gastroesophageal Varices Bleeding in Compensated Cirrhosis (CHESS1801) https://ClinicalTrials.gov/show/NCT03749954 Recruiting Nanfang Hospital of Southern Medical University 2019-11-08
NCT03746210 Non-Invasive Characterization of Focal Liver Lesions in Liver Cirrhosis https://ClinicalTrials.gov/show/NCT03746210 Recruiting University Hospital, Bonn 2025-12-31
NCT03726827 A Self Selected Population Study of Undiagnosed NAFLD and NASH, Using an Echosens FibroScan, in at Risk Populations https://ClinicalTrials.gov/show/NCT03726827 Completed Fatty liver Foundation 2019-08-30
NCT03723317 Associated Balance of Risk Score - Comprehensive Complication Index for the Prediction of Post-transplant Survival https://ClinicalTrials.gov/show/NCT03723317 Completed European Hepatocellular Cancer Liver Transplant Group 2018-10-15
NCT03694600 Clinical Trial for the IvyGene Liver Cancer Test https://ClinicalTrials.gov/show/NCT03694600 Recruiting Laboratory for Advanced Medicine, Indiana 2020-04-28
NCT03658551 Intestinal Permeability in Patients With Liver Cirrhosis Using Confocal Endoscopy https://ClinicalTrials.gov/show/NCT03658551 Recruiting Johannes Gutenberg University Mainz 2020-08-01
NCT03650660 Concordance Between Echocardiographic Assessment Performed in the Initial Phase of Decompensated Cirrhosis With Edema and Ascites by an Expert Intensive Care Physician and a Non-expert Gastroenterologist https://ClinicalTrials.gov/show/NCT03650660 Recruiting Centre Hospitalier Universitaire de Nīmes 2020-05-31
NCT03608748 Early Detection of Advanced Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03608748 Recruiting HaEmek Medical Center, Israel 2020-08-01
NCT03602573 Liver Fibrosis in Peri-menopausal Women https://ClinicalTrials.gov/show/NCT03602573 Recruiting Chang Gung Memorial Hospital 2019-07-31
NCT03598283 Liver, Pancreas and Thyroid Function in Burn Patients https://ClinicalTrials.gov/show/NCT03598283 Recruiting The University of Texas Medical Branch, Galveston 2019-06-30
NCT03590288 Dynamic Monitor of HVPG and Its Prognostic Value in Predicting Outcomes in Patients Undergoing TIPS https://ClinicalTrials.gov/show/NCT03590288 Recruiting Fourth Military Medical University 2021-06-01
NCT03587623 Copeptin Serum Level in Liver Transplant Recipients https://ClinicalTrials.gov/show/NCT03587623 Recruiting Medical University of Warsaw 2019-07-04
NCT03584204 Skeletal Muscle Parameters of Liver Cirrhosis in Non-invasive Imaging and Outcome https://ClinicalTrials.gov/show/NCT03584204 Recruiting University Hospital, Bonn 2025-07-31
NCT03571711 Meropenem Pharmacokinetics in Spontaneous Bacterial Peritonitis https://ClinicalTrials.gov/show/NCT03571711 Recruiting Hannover Medical School 2020-07-01
NCT03548597 Evaluation of the Diagnostic of Hepatic Fibrosis With the in Severe Obese Patients Candidates to Bariatric Surgery https://ClinicalTrials.gov/show/NCT03548597 Completed European Georges Pompidou Hospital 2015-01-12
NCT03539757 Development of Novel MRI Methods for Detecting, Discriminating, and Measuring Liver Fibrosis and Congestion in Fontan Patients https://ClinicalTrials.gov/show/NCT03539757 Recruiting Children’s Hospital Medical Center, Cincinnati 2023-04-30
NCT03531593 Dose Effect Relationship of MTX and IBD https://ClinicalTrials.gov/show/NCT03531593 Completed Children’s Mercy Hospital Kansas City 2018-05-31
NCT03525769 Screening With FibroTouch for Advanced Liver Fibrosis in NAFLD Patients With Underlying Type 2 Diabetes https://ClinicalTrials.gov/show/NCT03525769 Recruiting Nanfang Hospital of Southern Medical University 2025-12-31
NCT03513900 Non-invasive Methods to Predict PHG in Cirrhosis https://ClinicalTrials.gov/show/NCT03513900 Completed Second Affiliated Hospital of Xi’an Jiaotong University 2018-12-20
NCT03513887 Noninvasive Tests to Predict the Presence of Esophageal Varices in Patients With Liver Cirrhosis https://ClinicalTrials.gov/show/NCT03513887 Completed Second Affiliated Hospital of Xi’an Jiaotong University 2019-01-12
NCT03511573 ROLIVER - Prospective Cohort for the Identification of Liver Microbiota https://ClinicalTrials.gov/show/NCT03511573 Completed Tîrgu Mureș Emergency Clinical County Hospital, Romania 2016-12-31
NCT03509194 Better Diagnostic Tools for Children and Adolescents With Acute Liver Failure and Chronic Liver Insufficiency https://ClinicalTrials.gov/show/NCT03509194 Recruiting Rigshospitalet, Denmark 2020-12-17
NCT03508388 Value on Survival of Liver Volume After an Acute Decompensation of an Alcoholic Cirrhosis https://ClinicalTrials.gov/show/NCT03508388 Recruiting University Hospital, Montpellier 2020-12-31
NCT03483272 MRI to Assess the Effect of Terlipressin in Patients With Acute Hepatorenal Syndrome (HRS-AKI) https://ClinicalTrials.gov/show/NCT03483272 Recruiting Hvidovre University Hospital 2023-01-31
NCT03472742 An Follow-Up Study of Liver Cirrhosis https://ClinicalTrials.gov/show/NCT03472742 Recruiting Rohto Pharmaceutical Co., Ltd. 2021-07-31
NCT03459378 Outcome After TIPS https://ClinicalTrials.gov/show/NCT03459378 Completed Medical University of Graz 2019-03-01
NCT03458845 Prevalence of Sarcopenia and Undernutrition in Patients With Cirrhosis and Abdominal Hernia https://ClinicalTrials.gov/show/NCT03458845 Recruiting University of Sao Paulo 2021-03-31
NCT03446521 AGRA Before and After Liver Transplantation https://ClinicalTrials.gov/show/NCT03446521 Recruiting Medical University of Graz 2021-07-31
NCT03443934 Hemodynamic Alterations in Liver Cirrhosis Validated by Non-invasive MR Compared to Invasive Assessment https://ClinicalTrials.gov/show/NCT03443934 Recruiting Hvidovre University Hospital 2023-04-30
NCT03438916 MRI to Assess the Effect of Non-selective Beta-blocker in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT03438916 Recruiting Hvidovre University Hospital 2023-04-30
NCT03414398 Assessing Cirrhosis Quality of Care While Accounting for Cost https://ClinicalTrials.gov/show/NCT03414398 Recruiting New York Presbyterian Hospital 2021-01-01
NCT01241227 Prognosis Value of Transient Elastography and Non-invasive Markers of Fibrosis in Patients With Chronic Liver Disease https://ClinicalTrials.gov/show/NCT01241227 Completed Association HGE CHU Bordeaux Sud NA
NCT01217983 Utility of Renal Biomarkers in Cirrhosis https://ClinicalTrials.gov/show/NCT01217983 Completed University Hospital, Geneva 2012-10-31
NCT01213927 National Cohort of Uncomplicated Alcoholic Cirrhosis https://ClinicalTrials.gov/show/NCT01213927 Active, not recruiting Assistance Publique - Hôpitaux de Paris 2018-11-30
NCT01208311 Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic Ultrasound https://ClinicalTrials.gov/show/NCT01208311 Completed Northwell Health 2016-12-31
NCT01161953 Genetic Epidemiology of Primary Biliary Cirrhosis (PBC) https://ClinicalTrials.gov/show/NCT01161953 Active, not recruiting Mayo Clinic 2025-12-31
NCT01151475 Cerebral Oxygen, Blood Flow and Ammonia Uptake in Patients With Cirrhosis and an Acute Episode of Hepatic Encephalopathy (HE) https://ClinicalTrials.gov/show/NCT01151475 Completed University of Aarhus 2011-08-31
NCT01144507 Prediction by Ultrasound of the Risk of Hepatic Cirrhosis in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT01144507 Active, not recruiting National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2022-11-30
NCT02022150 Body Composition Analysis in Cirrhotic Undergoing Paracentesis https://ClinicalTrials.gov/show/NCT02022150 Recruiting Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 2021-06-30
NCT01002261 Hepatic Metabolism of Galactose and the Galactose Analog FDGal in Patients With Liver Disease and Healthy Subjects https://ClinicalTrials.gov/show/NCT01002261 Completed Aarhus University Hospital 2015-01-31
NCT00941902 A Potential Novel Marker for Liver Fibrosis in NASH: the Soluble Secreted Form of the Human Asialoglycoprotein Receptor https://ClinicalTrials.gov/show/NCT00941902 Completed Ziv Hospital 2010-09-30
NCT00913757 A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area https://ClinicalTrials.gov/show/NCT00913757 Completed National Institutes of Health Clinical Center (CC) 2020-05-01
NCT00883454 Estimation of Functional Liver Reserve Using Cholinesterases https://ClinicalTrials.gov/show/NCT00883454 Completed University of Milan NA
NCT03908294 Change of Glucose Metabolism and Fibrosis Markers in Patients With Hepatitis C Under Treatment With Antiviral Agents https://ClinicalTrials.gov/show/NCT03908294 Completed Johann Wolfgang Goethe University Hospital 2020-01-01
NCT03905746 Study of microRNAs in a Decompensated Cirrhosis https://ClinicalTrials.gov/show/NCT03905746 Recruiting Hospices Civils de Lyon 2021-06-26
NCT03663062 ObeSity Related Colorectal Adenoma Risk https://ClinicalTrials.gov/show/NCT03663062 Recruiting South Tyneside and Sunderland NHS Foundation Trust 2019-07-01
NCT02958592 Assessment of Hepatic Fibrosis by Shear Wave Elastography in Patients With Liver Malignancy: A Prospective Single-center Study https://ClinicalTrials.gov/show/NCT02958592 Completed Sun Yat-sen University 2016-03-31
NCT00827723 Indocyanine Green and Portal Pressure in Viral and Alcoholic Cirrhotic Patients With Hepatocarcinoma https://ClinicalTrials.gov/show/NCT00827723 Completed University of Lausanne Hospitals 2018-02-28
NCT04245189 EUS Based Prevalence of Chronic Pancreatitis in Alcoholic Cirrhosis https://ClinicalTrials.gov/show/NCT04245189 Recruiting Asian Institute of Gastroenterology, India 2020-10-31
NCT03483584 Incidence of HANA Conditions in HIV-infected Individuals https://ClinicalTrials.gov/show/NCT03483584 Recruiting Chinese University of Hong Kong 2022-01-31
NCT02468479 Prognostic Values of Chest/Abdominal Wall Varices and Spider Nevi in Patients With Liver Cirrhosis https://ClinicalTrials.gov/show/NCT02468479 Completed General Hospital of Shenyang Military Region 2016-12-31
NCT03345498 Entecavir for Decompensated HBV Cirrhosis https://ClinicalTrials.gov/show/NCT03345498 Completed Sanjay Gandhi Postgraduate Institute of Medical Sciences 2018-06-30
NCT02011932 Prospective Observational Study of Disease Progression in Chronic Hepatitis C https://ClinicalTrials.gov/show/NCT02011932 Active, not recruiting Beijing YouAn Hospital 2011-06-30
NCT00326482 Liver Fibrosis in HIV-Infected Patients With Elevated Liver Enzymes on Antiretroviral Therapy https://ClinicalTrials.gov/show/NCT00326482 Active, not recruiting National Institutes of Health Clinical Center (CC) NA
NCT04388150 Efficacy of Narrow Band Spectrum Endoscopy for the Diagnosis of Gastric Antral Vascular Ectasia in Patients With Liver Cirrhosis https://ClinicalTrials.gov/show/NCT04388150 Recruiting Alexandria University 2021-01-01
NCT03743272 Repeatability and Reproducibility of Multiparametric MRI https://ClinicalTrials.gov/show/NCT03743272 Recruiting Perspectum Diagnostics Ltd 2020-05-17
NCT02917408 Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital https://ClinicalTrials.gov/show/NCT02917408 Completed West China Hospital 2017-01-31
NCT03245606 Combining MRI Steatosis Assessment and Transient Elastography to Improve Liver Fibrosis Diagnosis in Non Alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03245606 Active, not recruiting Rennes University Hospital 2020-07-07
NCT02165488 Frequent Ketamine Use and Gastrointestinal, Liver and Biliary Sequelae https://ClinicalTrials.gov/show/NCT02165488 Completed The University of Hong Kong 2019-05-31
NCT04340999 Electrophysiological Evaluation of Motor Dysfunction in Liver Cirrhotic Patients https://ClinicalTrials.gov/show/NCT04340999 Completed Kasr El Aini Hospital 2019-12-31
NCT03225677 Novel Tracer Methods to Evaluate Muscle Protein Metabolism in Cirrhosis https://ClinicalTrials.gov/show/NCT03225677 Recruiting The Cleveland Clinic 2021-07-30
NCT03800069 Validation of Point of Care Liver Function Tests https://ClinicalTrials.gov/show/NCT03800069 Active, not recruiting University of Pennsylvania 2019-10-02
NCT00777725 Non-invasive Assessment of Liver Stiffness/Fibrosis by Transient Elastography (Fibroscan) in Patients With Left and/or Right Sided Heart Failure https://ClinicalTrials.gov/show/NCT00777725 Completed Monash University 2010-10-31
NCT00679692 Evaluation the Growth Factors(IGF-1,IGFBP-3and HGH)in Patients With Chronic Liver Disease https://ClinicalTrials.gov/show/NCT00679692 Completed Kaohsiung Medical University Chung-Ho Memorial Hospital 2008-03-31
NCT00673101 Prospective Evaluation of FibroScan in Patients Treated With Methotrexate https://ClinicalTrials.gov/show/NCT00673101 Completed Association HGE CHU Bordeaux Sud 2019-07-31
NCT00488917 Sepsis, Endothelial Function, and Lipids in Critically Ill Patients With Liver Failure (the SELLIFA Study) https://ClinicalTrials.gov/show/NCT00488917 Completed Cliniques universitaires Saint-Luc- Université Catholique de Louvain 2009-08-31
NCT00466336 Prediction of Hepatic Fibrosis in Patients With Chronic Hepatitis C by Biochemical and Duplex Doppler Indices https://ClinicalTrials.gov/show/NCT00466336 Completed National Taiwan University Hospital 2006-12-31
NCT00466271 Prediction of Significant Hepatic Fibrosis in HCV Carriers With PNALT by SAPI- A Validation Study https://ClinicalTrials.gov/show/NCT00466271 Completed National Taiwan University Hospital 2008-11-30
NCT00250315 DOCICAR: Cardiac Dysfunction in Cirrhosis https://ClinicalTrials.gov/show/NCT00250315 Completed Hvidovre University Hospital NA
NCT00245310 Indocyangreen Elimination in Cirrhosis and Acute Liver Failure https://ClinicalTrials.gov/show/NCT00245310 Completed Heidelberg University 2010-10-31
NCT00163631 Relationship of Vasoactive Peptide Levels to Portal Pressure and Patient Outcomes in Patients With Hepatic Cirrhosis https://ClinicalTrials.gov/show/NCT00163631 Completed Bayside Health NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03342170 Influence of ABO Blood Group on the Risk of Complications in Alcoholic or Viral C Cirrhosis? https://ClinicalTrials.gov/show/NCT03342170 Completed University Hospital, Caen 2019-12-31
NCT03267615 VICIS - Vienna Cirrhosis Study https://ClinicalTrials.gov/show/NCT03267615 Recruiting Medical University of Vienna 2026-12-31
NCT03263598 Validation of Diagnostic Usefulness of the Random Urine Na/K Ratio for Replacement of 24hr Urine Na Excretion in Cirrhotic Patients With Ascites https://ClinicalTrials.gov/show/NCT03263598 Completed Keimyung University Dongsan Medical Center 2020-02-29
NCT03146910 Swiss Primary Biliary Cholangitis Cohort Study https://ClinicalTrials.gov/show/NCT03146910 Recruiting Fondazione Epatocentro Ticino 2022-12-31
NCT02846896 The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland https://ClinicalTrials.gov/show/NCT02846896 Completed Fondazione Epatocentro Ticino 2016-09-30
NCT02828254 A Follow-up Evaluation Study of PRI-724-1101 https://ClinicalTrials.gov/show/NCT02828254 Completed Komagome Hospital 2017-03-27
NCT02693847 Natural History of Liver Cirrhosis Diagnosed by Transient Elastography in HIV/HCV-coinfected Patients https://ClinicalTrials.gov/show/NCT02693847 Recruiting Hospital Universitario de Valme 2020-12-31
NCT02031913 Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLD https://ClinicalTrials.gov/show/NCT02031913 Recruiting Seoul National University Boramae Hospital 2022-11-30
NCT02551250 Annual MRI Versus Biannual US for Surveillance of Hepatocellular Carcinoma in Liver Cirrhosis https://ClinicalTrials.gov/show/NCT02551250 Active, not recruiting Seoul St. Mary’s Hospital 2019-12-31
NCT02292706 A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection https://ClinicalTrials.gov/show/NCT02292706 Active, not recruiting Gilead Sciences 2023-01-31
NCT02038517 Cirrhosis, Effects of TRAnsplantation and Diabetes https://ClinicalTrials.gov/show/NCT02038517 Recruiting Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico 2016-12-31
NCT01962155 Prospective Stuy in Evaluating Hepatic Fibrosis Related to Hepatitis B Virus Using Non-invasive Parameters https://ClinicalTrials.gov/show/NCT01962155 Completed Peking University First Hospital 2015-12-31
NCT04442334 The European NAFLD Registry https://ClinicalTrials.gov/show/NCT04442334 Recruiting Newcastle University 2030-12-31
NCT04422223 Prospective Cohort Study of Disease and Outcomes in Cirrhosis https://ClinicalTrials.gov/show/NCT04422223 Recruiting Copenhagen University Hospital, Hvidovre 2024-12-30
NCT04329559 COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study https://ClinicalTrials.gov/show/NCT04329559 Recruiting Hepatopancreatobiliary Surgery Institute of Gansu Province 2020-06-29
NCT04326946 International Alfapump Cohort Study https://ClinicalTrials.gov/show/NCT04326946 Recruiting Sequana Medical N.V. 2023-12-31
NCT04277819 The Use of Novel Diagnostic Tools to Increase Detection of Early Fibrosis in Cystic Fibrosis Related Liver Disease to Improve Clinical Management https://ClinicalTrials.gov/show/NCT04277819 Recruiting Manchester University NHS Foundation Trust 2020-08-30
NCT03989973 Two-dimensional Shear-Wave Elastography Evaluate Esophageal Varices Bleeding Risk of Liver Cirrhosis https://ClinicalTrials.gov/show/NCT03989973 Recruiting West China Hospital 2022-09-01
NCT03973372 ALTA TIPS: A 5-year Longitudinal Observational Study of Patients Undergoing TIPS Placement https://ClinicalTrials.gov/show/NCT03973372 Enrolling by invitation Northwestern University 2024-07-31
NCT03842748 Non-invasive Diagnostic Model of Liver Fibrosis Associated With NAFLD and Prediction of Prognosis https://ClinicalTrials.gov/show/NCT03842748 Recruiting Beijing Municipal Administration of Hospitals 2021-12-30
NCT03837145 Propofol for Sedation of Postoperative Electively Ventilated Liver Transplant Recipients. https://ClinicalTrials.gov/show/NCT03837145 Recruiting Institute of Liver and Biliary Sciences, India 2019-03-31
NCT03676777 Study Of Bacterial/Fungal Infections in Hospitalized Patients With Liver Cirrhosis in China https://ClinicalTrials.gov/show/NCT03676777 Recruiting Ruijin Hospital 2019-12-31
NCT03599882 Liver Steatosis and Stiffness in HIV https://ClinicalTrials.gov/show/NCT03599882 Recruiting Chang Gung Memorial Hospital 2018-12-31
NCT01943318 Boramae Hospital Liver Cirrhosis Patient Cohort Study https://ClinicalTrials.gov/show/NCT01943318 Recruiting Seoul National University Boramae Hospital 2022-10-31
NCT04184934 Optimal Clinical Predictors to AKI in Cirrhotic Patients Experienced Acute Gastrointestinal Hemorrhage https://ClinicalTrials.gov/show/NCT04184934 Enrolling by invitation Taipei Veterans General Hospital, Taiwan 2020-01-30